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ABSTRACT OF THESIS 
 
 
 
DIET, BACTERIA AND INFLAMMATION:  
THE INTESTINAL MUCOSA AND METABOLIC SYNDROME 
 
Long term consumption of a high fat diet (HFD) increases the risk of 
developing Metabolic Syndrome and type 2 diabetes. This led us to hypothesize 
that long term HFD consumption impairs immune tolerance to the intestinal 
bacteria. Our studies had two goals. First, we characterized the effect of long 
term HFD consumption on the systemic immune response by comparing C57BL6 
mice fed a HFD and low fat diet (LFD). Plasma immunoglobulin G (IgG) against 
Escherichia coli (LF-82), E. coli (Nissle 1917), Bacteroides thetaiotaomicron and 
Lactobacillus acidophilus were measured by a lab-developed ELISA. Fasting 
blood glucose and inflammation were measured in LFD mice and HFD mice. To 
test whether our findings were clinically relevant, anti-bacterial IgG and TNF-α 
were measured in plasma samples from lean healthy individuals, obese non-
diabetics and obese diabetics. Our second aim was to investigate the 
relationship between HFD consumption and intestinal immunity. The effect of 
HFD consumption on immune responses in the GI tract was assessed by 
measuring fecal IgA levels in HFD mice and LFD mice. HFD mice had higher 
plasma IgG against the LF82 strain of Escherichia coli as well as higher plasma 
TNF-α, neutrophil percentage and fasting blood glucose levels. Obese diabetics 
had higher plasma IgG against the LF82 strain of E. coli than lean healthy 
controls. Studies on the effect of HFD on intestinal immunity revealed that HFD 
mice had lower fecal IgA than LFD mice. Our findings are novel in that they show 
an association between long term HFD consumption, systemic inflammatory 
immune responses to pathogenic intestinal bacteria and insulin resistance. 
These studies also showed that HFD consumption may impair intestinal 
immunity.  
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CHAPTER 1 INTRODUCTION 
Metabolic syndrome: a global public health threat. 
 The drastic increase in the prevalence of type 2 diabetes is a worldwide 
problem, with an estimated six percent of the world’s adults categorized as 
diabetic. The main impact of type 2 diabetes in the past has been in the 
developed world. However this is rapidly changing as a result of the increased 
affluence of developing nations. By the year 2025 it is projected that 300 million 
individuals will be diagnosed with diabetes worldwide with most new cases being 
from developing countries [1]. The diagnostic criteria for type 2 diabetes is a 
fasting plasma glucose level >126 mg dl-1 [2]. Untreated diabetes may lead to a 
variety of debilitating complications. These include coronary artery disease, 
peripheral vascular disease, blindness and amputations [3]. Therefore it is no 
surprise that the rise in prevalence of type 2 diabetes has been accompanied by 
an increased financial burden via increased medical expenditure as well as lost 
productivity [4]. As a consequence, investigators are interested in fully 
characterizing the underlying causes of diabetes to develop new strategies to 
prevent the development of this condition.  The dramatic surge in the number of 
diabetics has been attributed to the increase in the number of individuals who are 
overweight and obese. According to the guidelines set by the World Health 
Organization a body mass index (BMI) between twenty five and thirty qualifies an 
adult as being overweight. Obesity is defined as a BMI of thirty or higher [5].  
There has been a dramatic increase in the prevalence of obesity in all segments 
of American society in the past four decades [6]. It is estimated that a third of the 
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adults in the United States are obese [7]. Furthermore, seven in ten American 
adults can be categorized as being overweight and obese [8]. The increase in the 
prevalence of overweight and obese individuals has been accompanied by the 
increased prevalence of type 2 diabetes. As a result, excess body weight is an 
established risk factor for developing type 2 diabetes  [9]. While lifestyle choices 
are a major cause for the rise in the number of diabetics it is worth noting that 
not all diabetics are obese. Additionally not all obese individuals develop 
diabetes, since a third of adults are obese but the prevalence of type 2 diabetes 
in the total population is 8.3% [10]. There are other risk factors for developing 
diabetes. These include genetic defects of beta-cell function and genetic defects 
in insulin action [11]. 
Increased body weight results when the intake of calories exceeds the 
expenditure of calories. Surplus dietary calories are converted into triglyceride 
and stored. There are two major forces that have contributed to increased 
average bodyweight. The first is an increase in dietary intake as larger portions of 
food can be obtained at a cheaper cost. The second factor is a more sedentary 
lifestyle due to automation and limited physical activity. High caloric intake and 
sedentary lifestyle can predispose an individual to developing a variety of 
metabolic abnormalities including elevated triglyceride levels, reduced high 
density lipoprotein cholesterol levels and increased blood pressure values that 
may occur simultaneously with increased body weight. This is referred to as 
metabolic syndrome. 
3 
 
Metabolic syndrome (MetS), also referred to as metabolic syndrome X, 
syndrome X or insulin resistance syndrome, refers to a combination of risk 
factors that increases the risk of developing type 2 diabetes and cardiovascular 
disease [12]. It has been estimated that metabolic syndrome affects almost one 
quarter of US adults [13]. The risk factors for metabolic syndrome utilized by the 
National Cholesterol Education Program (NCEP) are any three of the following 
five risk factors: a waist circumference ≥ 102 centimeters (cm) in men or 88 cm in 
women, triglyceride levels ≥150mg/dL, high density lipoprotein cholesterol levels 
(≤50 in women, ≤40 in men), fasting blood glucose ≥100mg/dL) and systolic BP 
≥130mmHg and diastolic BP ≥85mmHg [14]. The International Diabetes 
Federation (IDF) criteria is waist circumference values ≥ 94 centimeters (cm) in 
men, ≥ 80 cm in women and any two of the other aforementioned risk factors.  
Introduction to the immune system. 
Since these studies involve characterization of immune responses, it is 
essential first of all to introduce some key immunology concepts. The immune 
system exists to protect the host from infection by potentially harmful 
microorganisms.  The human body is under the constant threat of infection by 
microorganisms. Microorganisms such as bacteria, viruses, fungi and parasites 
are ubiquitous. Although the majority of microorganisms are harmless, some 
species have the potential to cause disease and death.  Furthermore, there is 
also the threat of aberrant cellular replication which may lead to tumor 
development. To eliminate these threats the body has devised elaborate and 
diverse mechanisms that are highly specialized. 
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The entrance of microorganisms into the tissues and systemic circulation 
is termed infection. There are generalized mechanisms which protect against 
infection. The skin acts as a physical barrier which prevents infection. Chemical 
mechanisms also act against a broad range of infectious microbes. For example, 
lysozyme cleaves bacterial cell wall components. Lysozyme is present in nasal 
secretions, tears, on skin and in other bodily secretions [15]. A variety of immune 
cells eliminate infectious microorganisms. These include natural killer (NK) cells, 
macrophages and neutrophils [16-18]. These components of the host response 
are the first lines of defense against the establishment of infection. Inflammation 
also eliminates certain infections and it involves leukocytes and plasma proteins. 
The generalized mechanisms of immunity that eliminate microbes are collectively 
referred to as innate immunity.  
There are receptors which recognize molecular structures resulting from 
the presence of pathogens referred to as pattern recognition receptors (PRRs). 
There are membrane bound PRRs and cytoplasmic PRRs. The membrane 
bound PRRs include the C-type lectin receptors and the toll like receptors 
(TLRs). The C-type lectin receptors (CLRs) are present on dendritic cells and 
detect carbohydrate structures on pathogens [19]. CLRs play a vital role in the 
elimination of pathogens [20]. This is because detection by CLRs results in 
endocytosis and degradation of pathogens [21]. This facilitates the presentation 
of antigens for detection by the B and T lymphocytes. Another group of PRRs are 
the toll like receptors (TLRs). TLRs detect microbial compounds present on the 
surface of microbes such as lipopolysaccharide (LPS), peptidoglycan, flagellin 
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and lipotechoic acid. They also detect the genetic material of foreign 
microorganisms such as single stranded RNA, double stranded RNA as well as 
CpG-containing DNA. Detection of molecular structures found on 
microorganisms by TLRs triggers signaling cascades that culminate in NF-κB 
translocation into the nucleus and subsequent expression of genes encoding 
inflammatory products [22, 23].  
There are also cytosolic sensors to detect microbial products. These 
include the NOD-like receptors (NLRs) [24-26]. NLRs act by eliciting the 
production of inflammatory cytokines, antimicrobial peptides and interferon-β 
[27]. Alternatively, NLR activation results in procaspase-1 activation and the 
production of the inflammatory cytokines interleukin-1β (IL-1β) and IL-18 [28, 29]  
However, many pathogenic microorganisms have devised mechanisms 
that have enabled them to avoid the mechanisms of innate immunity. This has 
resulted in the development of elaborate and specific mechanisms of host 
immunity. These specific mechanisms of immunity which combat infections by 
microorganisms are characterized as the adaptive immune response. In 
addition to pathogen-specific effector mechanisms, another hallmark of the 
adaptive response is immunological memory. Subsequent infection by the same 
pathogen does result in disease since the immune system can mount a more 
rapid response. This prevents the reoccurrence of disease. The key components 
of the adaptive immune response are cells called lymphocytes that mature from 
lymphoid progenitors. Lymphocytes are categorized based on the location of 
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their maturation and their effector functions. There are two kinds of lymphocytes: 
B lymphocytes and T lymphocytes.  
B lymphocytes refer to lymphocytes which mature in the bone marrow and 
possess immunoglobulin receptors [30]. They detect antigens in soluble form via 
immunoglobulin receptors. They respond to infection by secreting antibodies. 
The binding of antibodies to antigens lead to their destruction via a variety of 
specialized immune pathways and cells. The next group of lymphocytes is the T-
lymphocytes. They possess T-cell receptors and mature in the thymus. The T-
lymphocytes can further be subdivided on the basis of surface markers and 
effector mechanisms [31]. Those that express the CD4-surface glycoprotein and 
respond to exogenous peptides are the CD4 T lymphocytes. Exogenous peptides 
are derived from phagocytosed antigens, e.g., extracellular protozoan parasites 
and bacteria. Those that bear the CD8 glycoprotein and respond to endogenous 
peptides are the CD8 T lymphocytes. Endogenous peptides are derived from 
proteins synthesized within the cell cytosol. These include the proteins 
synthesized in the cytosol by viruses or intracellular bacteria that have infected 
host cells.  
Inflammation is associated with Metabolic Syndrome. 
Some of the hallmarks of metabolic syndrome including central obesity, 
elevated blood glucose and hypertension have been shown to be associated with 
inflammation. Inflammation is a complex host defense mechanism that results 
from both internal and external stimuli [32]. Bacterial infection is a potent trigger 
of inflammation. Under normal circumstances the processes involved in 
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inflammation are self-limiting. However disease may arise if inflammation 
becomes continuous and chronic. A variety of disease states are associated with 
chronic inflammation. These include rheumatoid arthritis, Crohn’s Disease and 
systemic lupus erythematosus [33-35]. Chronic unwanted inflammation is also 
associated with impaired glucose tolerance [36]. It has been reported that when 
tumor necrosis factor alpha (TNF-α), an inflammatory marker is administered to 
cultured cells insulin action is impaired [37]. Furthermore, enhanced insulin 
sensitivity has been observed in obese mice deficient in functional TNF-α 
receptors [38]. These findings suggested that the insulin signaling pathway may 
be altered by TNF-α. Insulin is produced by the beta cells of the pancreas and it 
is essential to metabolic pathways of carbohydrate and fat [39]. Insulin interacts 
with cell surface receptors in adipose and muscle tissue. This results in 
autophosphorylation and phosphorylation of the insulin receptor substrate (IRS) 
family, initiating the insulin signaling pathway which culminates with glucose 
uptake. TNF-α and fatty acids have been shown to inhibit the phosphorylation of 
IRS-1, which in turn impairs insulin action [40, 41]. As a result deciphering the 
underlying causes of chronic systemic inflammation has become an important 
priority. 
High fat diet consumption and inflammation.  
Consumption of high levels of dietary fat are associated with the 
development of the obesity, insulin resistance, elevated blood pressure and 
dyslipidemia. Therefore, high fat diet consumption increases the risk of 
developing metabolic syndrome [42]. There has been an appreciable increase in 
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the fat content of food.  The most extreme cases can be found at some fast food 
restaurants where a single serving contains more than twice the recommended 
daily intake of saturated fat.  
Dietary fat itself has been implicated as the culprit that promotes 
inflammation. This is not surprising given the association between high fat diet 
consumption and inflammatory disorders. Furthermore, various studies have 
implicated high fat intake to the development of insulin resistance. Saturated fats 
and monounsaturated fatty acids have been shown to be detrimental to insulin 
signaling, while omega-3 fatty acids and polyunsaturated fatty acids do not 
negatively affect insulin signaling [43, 44]. Furthermore, the inhibition of insulin 
signaling has been attributed to increased free fatty acid levels [36]. As a 
consequence, it was imperative to investigate the role of fatty acids in promoting 
inflammation. Free fatty acids activated toll like receptor 4 signaling in adipocytes 
and macrophages [45]. Furthermore, myristic acid, palmitic acid and oleic acid 
induced interlukin-6 (IL-6) messenger RNA expression in the RAW264.7 
macrophage cell line. 
However, the role of fatty acids in promoting inflammation is controversial. 
It seems counterintuitive that the host would mount inflammatory immune 
responses against fatty acids. This is because fatty acids are integral in cell 
membrane structure and serve a variety of physiologic roles. Furthermore, a 
subsequent study showed that the bovine serum albumin (BSA) that had been 
complexed with fatty acids in the previous study were contaminated by 
lipopolysaccharide (LPS), the ligand of the toll like receptor 4 (TLR 4) [46]. Fatty 
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acids complexed with BSA elicted TLR dependent signaling. However, fatty acids 
by themselves were unable to elicit TLR signaling. The findings of this study cast 
serious doubt on the role of dietary fat as the causative factor for inflammation. 
Adipose tissue inflammation and insulin resistance. 
Adipose tissue was initially thought to be an inert triglyceride storage 
depot. However, the association between obesity and conditions such as type 2 
diabetes and cardiovascular disease prompted researchers to take a closer look 
at adipose tissue. It was observed that use of BMI values by itself was not an 
accurate means of predicting the risk of developing type 2 diabetes [47]. Visceral 
adipose tissue accumulation is associated with an increased risk of insulin 
resistance, whereas the subcutaneous adipose tissue depot is not associated 
with an increased risk of developing insulin resistance [48-51]. A variety of 
mechanisms have been proposed to explain how visceral adipose tissue 
accumulation results in the development of insulin resistance.  
 One proposed mechanism by which visceral fat promotes insulin 
resistance is the secretion of adipokines which impair insulin signaling in the liver 
and muscle tissues [52]. Excess lipid accumulation also promotes the 
development of insulin resistance. Saturated fatty acids may increase the 
biosynthesis of ceramide which may precede insulin resistance [53]. The 
conversion of triacylglycerols to diacylglyerols by adipose triglyceride lipase 
(ATGL) may also result in intracellular diacylgyercerol accumulation. ATGL 
activity has been shown to promote the development of insulin resistance [54]. 
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 Macrophage accumulation in visceral adipose tissue is another proposed 
mechanism by which adipose tissue may promote insulin resistance. The 
macrophages that accumulate in the adipose tissue release inflammatory 
cytokines, which can impair insulin sensitivity. It has been estimated that in lean 
mice and humans the percentage of macrophages is less than ten percent. This 
increases to forty percent in obese individuals [55]. Additionally, it was shown 
that macrophages present in the adipose tissue secrete a variety of inflammatory 
markers including TNF-α, iNOS and IL-6 [56-62]. It should also be noted that the 
adaptive immune response is involved in the inflammation that results from long 
term HFD consumption. CD4-T lymphocytes are present in the adipose tissue 
inflammation observed in mice fed a HFD [63]. Evidence suggests that the T 
lymphocytes may contribute to inflammation in the visceral adipose tissue prior to 
the recruitment of macrophages. Considering all these experimental findings, it is 
not surprising that inflammation associated with high fat diet intake was thought 
to be the result of excess adipose tissue accumulation. 
Linking intestinal bacteria, dietary fat and inflammation. 
Germ free mice (GF mice) were crucial in linking the intestinal bacteria to 
the obesity, inflammation and insulin resistance. Germ free mice do not harbor 
microorganisms [64]. This is because they are reared in sterile isolators which 
prevent them from being colonized by bacteria, viruses and eukaryotic parasites. 
The intestinal bacteria have been linked to the development of obesity [65]. 
Three groups of adult B6 male mice were analyzed; GF mice, mice colonized by 
intestinal bacteria from birth to adulthood (conventionally raised, CONV-R) and 
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GF mice colonized with bacteria from the cecum (conventionalized, CONV-D). 
GF mice had significantly lower body fat percentage compared to CONV-R and 
CONV-D mice. Furthermore, the epididymal fat pads of GF mice weighed less 
than CONV-R and CONV-D mice. These findings were intriguing since the GF 
mice consumed more food and had lower metabolic rates than the CONV-R and 
CONV-D mice. These findings were confirmed in a subsequent study when it 
was observed that GF mice are less prone to becoming obese after long term 
consumption of a high-fat, high-carbohydrate Western Diet [66]. These studies 
indicated that the intestinal bacteria may play a role in the development of 
obesity. 
However, it was a study by Rabot et al that showed the full extent of the 
effects of the intestinal bacteria. GF C57BL/6J mice and conventionally raised 
(conv) C57BL/6J mice were fed a high fat diet (60% of energy from fat). The GF 
mice had improved metabolic parameters compared to conventionally raised 
(conv) controls [67]. These included lower fasting blood glucose levels compared 
to the conventional controls on the high fat diet (conv/HF) as well as lower 
plasma insulin concentrations and showed improved response to an oral glucose 
challenge. GF/HF mice also had significantly lower plasma TNF-α, serum 
amyloid A (SAA), leptin and IFN-γ levels. Collectively these studies implicated 
the intestinal bacteria in the development of obesity and accumulation of adipose 
tissue. Furthermore, they showed that the intestinal bacteria play a role in the 
development of systemic inflammation and insulin resistance. However, these 
studies failed to identify the point of origin of the systemic inflammation.  
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The growing body of evidence linking the intestinal bacteria to the 
development of obesity and inflammation suggests that inflammation is not solely 
due to adipose tissue depots. Studies had also shown that the gut microbiota 
differed between obese and lean mice, as well as lean and obese human 
subjects [68]. These findings suggested that the GI tract may be the source of 
inflammation. This is not an unreasonable proposal. There are situations where 
intestinal inflammation occurs, giving rise to a variety of debilitating conditions, 
including Crohn’s Disease and Ulcerative Colitis [69]. 
The GI tract as the source of inflammation.  
A study performed by Ding et al was the first to investigate whether high 
fat diet consumption in combination with the intestinal bacteria can result in pro-
inflammatory changes within the GI tract [70]. Conventional specific pathogen 
free (SPF) C57BL/6 mice and GF mice were fed a HFD (45% kcal from fat) or a 
LFD (10% kcal from fat). Their findings were in accordance to previous studies 
using GF mice. GF mice on a HFD gained less weight than CONV controls, were 
more responsive to insulin and had lower levels of inflammatory plasma 
cytokines. TNF-α levels in the ileum of CONV/HFD was significantly increased 
compared to CONV/LFD mice whereas there was no increase in ileal TNF-α 
levels in the GF/HFD mice. This provides evidence that the GI tract is the point of 
origin of inflammation. The GI tract contains large numbers of immune cells 
which regulate the intestinal bacteria in a non-inflammatory manner. 
Inflammation of the GI tract can result in severe gastroenterological disorders, 
collectively referred to as inflammatory bowel disease (IBD). A variety of factors 
13 
 
are associated with IBD. These include certain pathogenic bacteria as well as 
defects in the immune system. For example certain strains of E. coli are 
associated with Crohn’s Disease [71, 72]. With regards to the immune system, 
defective sensors for molecular structures located on pathogenic microbes result 
in chronic inflammation [73, 74]. These include mutations in constituents of the 
inflammasomes [75]. Inflammasomes by definition are protein complexes 
capable of eliciting immune responses to a variety of stimuli including bacteria 
[76]. NLRP6 deficiency leads to reduced IL-18 and outgrowth of the 
Bacteroidetes. This promoted the development of colitis (inflammation of the 
colon).   
The intestinal bacteria are a source of inflammatory molecules. 
An estimated one hundred trillion (1014) microorganisms reside in the 
gastrointestinal tract [77]. To put things in perspective the number of 
microorganisms in the GI tract is so immense that intestinal microbes outnumber 
the total number of cells in the host by a factor of ten. The overwhelming majority 
of microorganisms that inhabit the GI tract are bacteria. Smaller numbers of 
archea and eukarya are also present [78]. Characterization of the intestinal 
bacteria remains challenging. There is considerable variability in the bacterial 
composition between different individuals. Furthermore, most of the intestinal 
bacterial species are anaerobic and difficult to culture using conventional 
methods. Advances in molecular techniques have facilitated characterization of 
the intestinal bacteria. Sequencing of the 16S ribosomal RNA gene (rRNA) led 
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researchers to identify the dominant intestinal bacterial divisions as the 
Bacteroidetes and the Firmicutes [79]. 
Pyrosequencing, which involves the detection of chemiluminescent signals 
subsequent to DNA synthesis has led researchers to identify in excess of 5,000 
bacterial taxa [80]. The majority of the intestinal bacterial species belong to the 
phyla Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria and 
Verrucomicrobia [81]. The large and diverse bacterial population of the 
gastrointestinal (GI) tract is a rich source of inflammatory molecules. 
Lipopolysaccharide (LPS) is present in the outer cell membranes of the gram 
negative intestinal bacteria [82]. LPS is a potent inducer of inflammation, 
triggering the release of pro-inflammatory cytokines such as TNF-alpha, IL-6, and 
IL-1 [83]. It should be noted that gram positive bacteria residing in the GI tract 
can also trigger inflammation. Bacterial DNA from gram positive bacteria induces 
inflammation [84]. Furthermore, long term HFD consumption is associated with 
increased plasma LPS. Long term HFD consumption increases LPS containing 
bacteria residing in the GI tract [85]. It was observed that LPS infusion results in 
insulin resistance, thereby establishing a crucial link between the contents of the 
GI tract, inflammation and insulin resistance.  
Regulation and confinement of the intestinal bacteria.  
Considering the sheer quantity of inflammatory molecules within the GI 
tract, it is not surprising that a variety of mechanisms exist to prevent intestinal 
bacteria from entering the systemic circulation. The intestinal epithelial cells 
(IECs) form a physical barrier referred to as the intestinal epithelial-cell barrier 
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[86]. The IECs also possess a brush border, which is an actin rich microvilli 
covered surface on the apical surface of the IECs. This prevents the intestinal 
bacteria from adhering to the surface, thereby minimizing bacterial invasion of 
the epithelial layer. Furthermore, the proteins occludin and claudin form tight 
physical seals at the apical epithelial surface [87, 88]. However, it should be 
noted that these so called tight junctions are not fully impermeable since the GI 
tract has to absorb a variety of nutrients and ions. Goblet cells also play a role in 
preventing the intestinal bacteria from adhering to the epithelial layer. Goblet 
cells are differentiated epithelial cells which secrete mucus. The secretion of 
mucus forms a viscous impermeable glyocalyx which prevents bacterial adhesion 
to the epithelium of the GI tract [89].   
The IECs do not only function as a physical barrier. They also act by 
secreting a variety of host defense peptides that kill bacteria. These include 
defensins and cathelicidins which have broad spectrum antibiotic activity [90, 91]. 
Defensins and cathelicidins are cationic proteins. These antimicrobial proteins 
function by forming pores in bacterial cells walls. IECs are not the only cells that 
secrete these antimicrobial peptides. Paneth cells, which are specialized 
epithelial cells, secrete antimicrobial peptides [92]. In additions to defensins and 
cathelicidins other anti-microbial compounds have been identified including 
phospholipases, lysozyme, and Reg III-gamma [93-97]. 
Intestinal epithelial serum amyloid A (SAA) also plays a role in regulating 
the intestinal bacteria population. SAA regulates Gram-negative bacteria present 
in the lumen of the GI tract, including E. coli [98]. SAA binds to the outer 
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membrane protein A (OmpA) of E. coli, which leads to its elimination by 
neutrophils [99]. SAA also promotes homeostasis with the intestinal bacteria, 
since SAA deficient mice are more susceptible to dextran sodium sulfate (DSS)-
induced colitis [100] . The production of such a diverse array of antimicrobial 
compounds emphasizes the importance of regulating the immense population of 
bacteria residing within the lumen of the GI tract.  
Adaptations of intestinal immunity. 
It has been previously stated that the immense antigenic load of the GI 
tract is a vast reservoir of inflammatory molecules. As a consequence a number 
of mechanisms exist to prevent the huge bacterial population of the lumen of the 
GI tract from entering the systemic circulation. Entrance of the immense 
antigenic load into the systemic circulation has the potential to result in 
catastrophic consequences including systemic shock and sepsis. Furthermore, 
the GI tract is also exposed to a variety of pathogens that are ingested by the 
host. The large surface area of the GI tract (approximately 300m2) makes it 
especially susceptible to infection. In order to prevent bacteria from the lumen of 
the GI tract from undergoing uncontrolled proliferation and entering the 
circulation, the GI tract contains a vast and diverse population of immune cells. 
The GI tract contains B and T lymphocytes, dendritic cells as well as the largest 
reservoir of macrophages (Mψ) in the body [101]. The immune cells are located 
in specialized structures including the Peyer’s Patches as well as in isolated 
lymphoid follicles.  
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However, a paradox exists. On one hand, the presence of immune 
defenses is required to prevent the intestinal bacteria from entering the systemic 
circulation. However, it is crucial that the intestinal bacteria be regulated without 
inflammation. Failure to engage bacteria without inflammation can have 
catastrophic consequences that are usually observed in patients with 
inflammatory bowel diseases such as ulcerative colitis (UC) and Crohn’s Disease 
(CD) [102]. Furthermore it is essential that the immune system tolerate the 
intestinal bacteria since some bacterial species perform vitamin K and biotin 
synthesis [103-105]. Additionally, the intestinal bacteria may play a role in the 
overall health of the digestive system [106]. Germ-free animals are more 
susceptible to infection [107]. 
Although intestinal macrophages are abundant, they possess a variety of 
modifications that render them inert against the bacteria in the lumen of the GI 
tract. These include a lack of receptors that may activate inflammatory pathways 
such as CD14, complement receptors (CR) and the triggering receptor 
expressed on myeloid cells (TREM-1) [108, 109]. It was initially proposed that the 
intestinal macrophages did not express toll like receptors (TLRs) [110]. However, 
further analysis revealed that intestinal macrophages do in fact express toll like 
receptors [111]. The reason for these macrophages existing in an anergic state is 
a lack of downstream signaling molecules including MyD88, IRAK and TRAF6 
[112-115]. The presence of molecules that inhibit TLR pathways such as IRAK-M 
also play a role in rendering intestinal macrophages hyporesponsive [116]. 
Impaired TLR signaling prevents the transcription factor NF-κB from translocating 
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into the nucleus. This prevents the expression of inflammatory genes and 
inflammatory cytokines.  
Another mechanism of intestinal immune tolerance is the inhibition of 
inflammatory cytokine production by antigen presenting cells (APCs). APCs are 
cells which express major histocompatibility complex (MHC) molecules which 
bind and present antigenic peptides for recognition by the T lymphocytes [117]. 
Dendritic cells (DCs) are specialized APCs which can induce cell mediated 
immune responses by the T lymphocytes [118]. However, the DCs are also 
capable of inducing tolerance to certain antigens, including those of the intestinal 
bacteria. The intestinal epithelial cells (IECs) secrete certain factors which limit 
inflammatory cytokine production by DCs. The most prominent of these IEC 
derived factors are thymic stromal lymphopoietin (TSLP), transforming growth 
factor-β (TGF-β), Interleukin-10 (IL-10) and prostaglandin E2 [119-122]. These 
IEC derived factors create a microenvironment that promotes the tolerogenic 
phenotype of dendritic cells.  
The adaptive immune response to the intestinal bacteria. 
In addition to the aforementioned generalized mechanisms, specialized 
immune responses occur to prevent the intestinal bacteria from entering the 
systemic circulation.  Since the 1960’s, researchers have observed that the vast 
majority of immunoglobulins in the external secretions belong to the 
immunoglobulin A (IgA) isotype [123]. IgA exists in a monomeric form or a 
polymeric form. The predominant form of secreted polymeric IgA (pIgA) is 
dimeric IgA, which is comprised of two IgA subunits bridged by the J chain 
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polypeptide [124]. Plasma cells present in the lamina propria secrete dimeric IgA  
[125].  
The polymeric immunoglobulin receptor (pIgR) is responsible for 
transepithelial transport of polymeric IgA and IgM [126]. pIgR binds and 
internalizes polymeric immunoglobulin at the basolateral surface of the intestinal 
epithelial cells. The bound immunoglobulin is shuttled through the cell to the 
apical surface where it is secreted. It is secreted with the extracellular ligand-
binding fragment of pIgR as secretory IgA (sIgA) [127]. Adherence and invasion 
of the intestinal epithelium by bacteria is minimized by secretory IgA (sIgA) and 
secretory IgM (sIgM) [128-130]. IgA is the predominant immunoglobulin subclass 
produced in the GI tract [131]. The IgA subclass accounts for four fifths of the 
immunoglobulins produced in the duodenum and jejunum. IgA comprises ninety 
percent of the immunoglobulins produced in the colon.  
In addition to its established role in preventing the bacteria present in the 
lumen of the GI tract from entering the systemic circulation, sIgA is essential to 
preventing inflammatory responses. sIgA minimizes inflammatory immune 
responses against the commensal bacteria by downregulating the expression of 
the inflammatory cytokines TNF-α, IL-6, Cox-2 and IFN-γ [132]. The presence of 
intestinal bacteria stimulates the production of intestinal IgA [133, 134]. Although 
the vast majority of IgA is produced at the intestinal mucosa, there is also IgA 
present in the plasma. Plasma IgA production is independent of intestinal IgA 
production [135]. Plasma IgA is primarily monomeric and is produced by B 
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lymphocytes resident in the bone marrow [136]. Small quantities of monomeric 
serum IgA enter intestinal secretions by diffusion [137].  
Figure 1.1 IgA secretion  
 
 
. Within the lamina propria plasma cells secrete dimeric IgA. The 
polymeric immunoglobulin receptor (pIgR) present on the basolateral end of 
intestinal epithelial cells binds IgA dimers. The IgA dimers are transported to the 
apical end and secreted into the lumen of the GI tract with a portion of pIgR.  
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pIgR knockout mice: defining the role of active IgA secretion. 
Dimeric IgA and pentameric IgM exported by the polymeric 
immunoglobulin receptor are not the only immunoglobulins present in the 
intestinal muocsa. Serum IgA and IgG also enter intestinal mucosal secretions by 
paracellular diffusion. Mice deficient in the polymeric immunoglobulin receptor 
(pIgR KO mice) were generated to characterize the role of active immunoglobulin 
secretion by insertion of a targeting vector into the third exon of the polymeric Ig 
receptor locus (PIGR). Immunofluorescence staining of small intestine sections 
revealed that pIgR KO mice have significantly reduced IgA at the epithelial 
surface compared to wild type controls. However, pIgR KO mice have increased 
interstitial IgA indicating that the lack of IgA at the epithelium is due to impaired 
active transport, not to a defect in IgA synthesis. Comparison of serum, whole 
saliva, small intestinal secretions and fecal extracts revealed a number of major 
differences between pIgR KO mice with wild type controls.  pIgR KO mice had 
elevated serum IgA. This was the direct result of impaired IgA secretion since 
Western Blot analysis revealed that the majority of this IgA was polymeric IgA. 
pIgR KO mice had increased serum anti-E. coli IgG. However, there was no 
difference in anti-Lactobacillus IgG between pIgR KO mice and wild type 
controls. Therefore, reduced active secretion of IgA by pIgR resulted plasma IgG 
being produced selectively against E. coli. IgG was higher in the small intestinal 
secretions of pIgR KO mice than in the wild type controls.  Fecal IgG was also 
significantly higher in pIgR KO mice than in the wild type controls. This shows 
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that impairment of the mucosal barrier results in the bulk transport of IgG into the 
mucosa.  
Studies have been performed using pIgR KO mice to determine the role of 
active immunoglobulin secretion in protection against disease. pIgR KO mice are 
more susceptible to Mycobacterium bovis bacillus Calmette-Guérin (BCG) 
infections than wild-type mice [138]. pIgR KO mice had higher bacterial loads in 
their lungs compared to the wild-type controls. The capacity of pIgR KO mice to 
produce IFN-γ and TNF-α was also significantly reduced compared to wild type 
controls. pIgR KO mice are also more susceptible to nasal colonization by 
Streptococcus pneumonia [139] . Wild type C57BL/6 mice had significantly less 
serum IgG against intestinal bacterial antigens than pIgR KO mice. pIgR KO 
mice also had increased numbers of bacteria in their mesenteric lymph nodes 
than wild type controls. These findings provide evidence that active IgA secretion 
is essential in the containment of bacteria to the lumen of the GI tract [140].  
Immune responses to intestinal bacteria are localized.  
As previously stated, immune responses are mounted against the 
intestinal bacteria. These immune responses involve the generation of IgA 
exclusively within the GI tract [141]. A study by Konrad et al characterized 
systemic immune responses against select intestinal bacterial antigens [142]. 
ELISA assays revealed that the serum immunoglobulin G (IgG) response to 
these antigens was negligible in C3H/HeJ mice. Furthermore, there were no 
specific CD4+ T-cell responses to bacterial antigens. However, although these 
mice did not have systemic immune responses against bacterial protein antigens 
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they produced intestinal IgA to the same antigens. This provides strong evidence 
of a very tight compartmentalization of immunity.  
Mesenteric lymph nodes are crucial for oral tolerance. 
There is an abundance of antigens in the GI tract. These include bacterial 
antigens as well as numerous food antigens. The oral administration of antigens 
significantly impairs systemic immune responses to these same antigens if they 
are administered intravenously. This phenomenon is referred to as oral tolerance 
[141]. Mesenteric lymphadenectomy (the removal of mesenteric lymph nodes) 
abolishes oral tolerance [143]. This provides evidence that the mesenteric lymph 
nodes (MLNs) are the sites of induction of tolerance to harmless antigens 
present in the GI tact. The MLNs act as barriers, preventing the dendritic cells 
carrying commensal bacteria from gaining access to the systemic circulation 
[144]. The inability of dendritic cells carrying commensal bacteria to enter the 
systemic circulation is a major contributing factor in preventing systemic immune 
responses to the intestinal bacteria.  
The MLNs are situated along the route of chylomicron transport [145]. 
Chylomicrons are lipoprotein particles secreted by the enterocytes subsequent to 
consuming a meal containing triglycerides [146]. Triacylglyceride (TAG) is the 
major constituent of chylomicrons. In addition to TAGs chylomicrons contain 
phospholipids, cholesterol as well as proteins [147]. Chylomicrons are comprised 
of a hydrophobic core containing TAG and cholesterol esters. The hydrophilic 
surface is a phospholipid monolayer in addition to cholesterol and proteins. It is 
therefore possible that the long term consumption of high levels of dietary fat can 
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affect the functioning of the mesenteric lymph nodes. Atrophy of the mesenteric 
lymph nodes has been observed in obese mice along with a reduction in the 
numbers of regulatory T lymphocytes.  Long term consumption of a high fat diet 
is associated with apoptosis of the regulatory T lymphocytes within the MLNs 
[148].  
The regulatory T cells (Tregs) downregulate immune responses, 
preventing uncontrolled immune responses [149]. A reduction in Tregs due to 
long term consumption of a HFD may result in a switch from tightly regulated 
immune responses to the intestinal bacteria to uncontrolled systemic 
inflammation. These findings were exciting since they demonstrated that the 
implications of long term HFD consumption may also extend to impairment of 
immune tolerance.  If this occurs then a switch from the tightly controlled non-
inflammatory responses against the intestinal bacteria to systemic inflammatory 
responses against the intestinal bacteria could result. Loss of tolerance to the 
intestinal bacteria being linked to metabolic syndrome was a novel concept that 
we sought to investigate in a series of studies.  
Proposed hypothesis. 
Based on our preliminary findings and the published literature we propose 
that long term consumption of a high fat diet impairs the immune tolerance to the 
intestinal bacteria resulting in increased systemic inflammation. This systemic 
inflammation may become chronic and lead to impaired insulin signaling and the 
development of type 2 diabetes. 
25 
 
Type 2 diabetes 
Impaired insulin signalling 
Systemic inflammation becomes chronic 
Inflammation 
Intestinal bacteria breaches intestinal 
epithelium 
Impaired intestinal IgA barrier 
Long term consumption of a high fat diet 
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Experimental approach.  
In previous studies, HFD fed mice harboring gut bacteria had higher 
fasting blood glucose levels and elevated plasma inflammatory cytokines than to 
HFD fed GF mice. As a result, our first experimental goal was to determine 
whether long term HFD consumption resulted in triggering of systemic immune 
response against intestinal bacteria. We assessed the effect of long term HFD 
consumption on plasma IgG against different intestinal bacterial strains. 
Preliminary analyses revealed that long term HFD consumption resulted in 
increased plasma IgG against the LF-82 strain of Escherichia coli, an invasive 
intestinal bacterial strain.sIgA in the GI tract plays a major role in preventing 
adherence of bacteria to the intestinal epithelium. This minimizes intestinal 
bacterial translocation. As a consequence, our second experimental goal was to 
determine whether long term HFD consumption affected IgA secretion into the 
lumen of the GI tract.  This was done by comparing fecal IgA in C57BL6 mice fed 
a low fat diet (LFD) as well as HFD mice. Our third goal was to characterize the 
role of the polymeric immunoglobulin receptor (pIgR) in shaping the bacterial 
composition of the GI tract. The polymeric immunoglobulin receptor (pIgR) is a 
membrane glycoprotein is responsible for the active secretion of polymeric 
immunoglobulins into the lumen of the GI tract. Mice lacking the pIgR (pIgR KO 
mice) and wild-type C57BL6 littermates were placed on a high-fat, high-
carbohydrate Western Diet and a variety of metabolic parameters were 
evaluated.  
Copyright © Nadeem K. Mohammed 2012 
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CHAPTER 2 THE EFFECT OF HIGH FAT DIET ON SYSTEMIC 
IMMUNITY. 
INTRODUCTION. 
Studies showing improved metabolic parameters in GF mice prompted an 
investigation as to whether the bacteria residing in the GI tract are responsible for 
the development of inflammation and insulin resistance. As previously 
mentioned, immune responses against the bacteria in the GI tract are generated 
at the intestinal mucosal surface. Theoretically the systemic immune cells are 
oblivious to the presence of intestinal bacteria. Serum immunoglobulin G (IgG) 
and CD4+ T-cell specific responses against intestinal bacterial antigens are 
negligible.  
To gain a more comprehensive understanding of the effects of long term 
HFD consumption, pilot studies were performed using the plasma from BALBc 
mice fed a high fat diet (Research Diets Inc. D12492 Rodent Diet with 60% kCal 
fat) and mice fed a low fat diet (Open Source Diets D12450B Rodent Diet with 10 
kcal% fat) for 10 weeks. The pilot analyses involved measuring plasma IgG 
against the LF82 strain of E. coli, an intestinal bacterial strain. Plasma IgG was 
evaluated by Western Blot analysis, as well as by ELISA analysis. After 
performing the preliminary studies in mice, a 10 week feeding study was 
performed on C57BL6 mice fed a HFD and a LFD. Plasma IgG against protein 
extracts from E. coli LF82, E. coli Nissle 1917 (EcN), Bacteroides 
thetaiotaomicron (B. thetaiotaomicron) and Lactobacilus acidophilus (L. 
acidophilus) were measured by a lab-developed ELISA. Plasma TNF-α, blood 
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cell composition and fasting blood glucose levels were measured in order to 
determine whether a link existed between plasma IgG against intestinal bacteria, 
systemic inflammation and elevated fasting blood glucose.  
To determine whether the findings in the animal studies were clinically 
relevant, plasma samples from human subjects were also analyzed. Plasma IgG 
against E. coli LF82, E. coli Nissle 1917 (EcN), Bacteroides thetaiotaomicron (B. 
thetaiotaomicron) and Lactobacilus acidophilus (L. acidophilus) was measured in 
lean healthy controls as well as obese non-diabetics and obese diabetics. 
Plasma TNF-α was also measured in human plasma samples to determine 
whether a relationship existed between plasma IgG against intestinal bacteria 
and inflammation. The findings of this study can be found in the journal 
Metabolism: Clinical and Experimental. The title of the paper is Elevated IgG 
levels against specific bacterial antigens in obese patients with diabetes 
and in mice with diet-induced obesity and glucose intolerance. The article is 
available online and it is currently still in press. Permission to reproduce this data 
was obtained. 
METHODS. 
PRELIMINARY ANIMAL STUDIES 
The preliminary studies involved the analysis of plasma from eight BALB/c 
mice. Four of the mice had been placed on a high fat diet (Research Diets Inc. 
D12492 Rodent Diet with 60% kCal fat) and the other four had been placed on a 
low fat diet (Open Source Diets D12450B Rodent Diet with 10 kcal% fat) for ten 
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weeks. Western blots were performed to determine whether long term HFD 
consumption was associated with increased plasma IgG against the intestinal 
bacteria. 
Bacterial cultures. 
The LF82 strain of the gut microbe Eschericha coli was cultured overnight 
in Luria-Bertani Medium (LB Medium) at 36.9°C in an Isotemp Incubator (Fisher 
Scientific). 
Preparation of bacterial proteins. 
In order to obtain bacterial proteins, approximately 5 ml of bacterial 
cultures were centrifuged at 10,000 rpm for ten minutes. The supernatant was 
discarded and the bacterial pellet obtained was re-suspended in two hundred 
and fifty microliters (250µl) 4X SDS and seven hundred and fifty microliters 
(750µl) water. The re-suspended bacterial pellet was then boiled for ten minutes.  
Western Blot Analysis of anti-E. coli LF82 IgG. 
The E. coli proteins were separated on NuPAGE® 4-12% Bis Tris Gels and 
then transferred by an Invitrogen iBlot® Gel Transfer Device to PVDF 
membranes. The membranes were blocked with non-animal protein (NAP) 
blocking solution diluted 1:2 with 1X femto-TBST. The PVDF membranes were 
cut into individual strips. Each membrane strip was incubated overnight in 
plasma from an individual mouse that had been diluted 1:10 in the blocking 
solution. The membrane strips were then washed with 1X Tris-Buffered Saline 
Tween-20 (TBST). Anti-Mouse IgG (Fc specific)-Peroxidase antibody was diluted 
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1:5000 to detect the presence of anti-E.coli IgG. The membrane strips were then 
washed again with TBST and then simultaneously exposed to ECL Western 
Blotting Substrate. The western blots were then visualized on the Kodak Image 
Station 440. 
Western Blot Analysis of plasma anti-bacterial IgG. 
The intestinal bacteria are poorly characterized. To determine whether 
long term HFD consumption resulted in increased systemic immune responses to 
the intestinal bacteria, the contents of the cecum were isolated. The contents of 
the cecums were removed from each of the LFD mice, pooled and added to 
750µl of water and 250µl 4X SDS loading buffer. The mixture was boiled for 
approximately ten minutes. The mixture was then centrifuged at 10,000 rpm for 
ten minutes. The pellet was discarded while the supernatant containing the cecal 
antigens was kept for analysis. The cecal antigens were separated on NuPAGE® 
4-12% Bis Tris Gels and then transferred by an Invitrogen iBlot® Gel Transfer 
Device to PVDF membranes.  
Each membrane was cut into four individual strips. Each individual 
membrane strip was placed in non-animal protein (NAP) blocking solution diluted 
1:2 with 1X femto-TBST. Each membrane strip was incubated overnight in 
plasma from an individual mouse that had been diluted ten times in the blocking 
solution. The membrane strips were then washed with Tris-Buffered Saline 
Tween-20 (TBST) [1X]. Anti-Mouse IgG (Fc specific)-Peroxidase antibody was 
diluted 1:5000 to detect the presence of anti-E.coli IgG. The membrane strips 
were then washed again with TBST and then simultaneously exposed to ECL 
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Western Blotting Substrate. The western blots were then visualized on the Kodak 
Image Station 440. 
Development of a novel ELISA technique to quantify anti-bacterial 
IgG. 
We wanted to assess whether long term HFD consumption resulted in 
quantitative differences in IgG against bacterial proteins. To do this we 
developed a novel enzyme-linked immunosorbent assay (ELISA) to measure IgG 
against the bacteria used in these studies: E. coli LF82, E. coli Nissle 1917, 
Bacteroides thetaiotaomicron and Lactobacilus acidophilus. Soluble proteins 
from these bacteria were extracted using B-PER Bacterial Protein Extraction 
Reagents (ThermoSCIENTIFIC). Bacteria cultures were centrifuged at 5000 × g 
for 10 minutes.  
The supernatant was discarded and the remaining pellet was weighed. B-
PER Reagent was added at a ratio of 4ml/gram of cell pellet. Lysozyme and 
DNase I were added at a ratio of 2μL/mL of B-PER Reagent in order to obtain a 
higher concentration of soluble proteins. The suspension was incubated at room 
temperature for 15 minutes and then centrifuged at 15,000 × g for 5 minutes. The 
supernatant containing soluble bacterial proteins was used for preparing the 
ELISA plates. Bacterial proteins were quantified using the BCA™ Protein Assay 
(Thermo Scientific) and dissolved in a carbonate coating buffer of pH 9.6 to give 
a final concentration of 100µg/ml. 96 well flat-bottom ELISA plates (BD-Falcon) 
were coated with 10μg of bacterial protein per well and incubating the plate 
overnight at 4ºC. Details of how the ELISAs were performed are given below. 
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Long term feeding study on C57BL6 mice. 
 
Twelve six week old male C57BL6 mice were ordered at 5 weeks of age 
from Jackson Laboratories. The mice were housed three per cage and 
maintained in a 12hour light/dark cycle. We allowed the mice to become 
acclimated to their environment.  We then marked them for identification using 
tail markings. We measured the body weight and fasting blood glucose values 
prior to switching these mice from regular chow diets to special diets.  
The special diets of the mice were open formula, open source purified 
ingredients. The mice were divided into two equal groups (n = 6). One group was 
fed a high fat diet (Rodent Diets with 60 kcal% Fat D12492 from Research Diets 
Incorporated). The other group was fed a low fat diet (Rodent Diets with 10 
kcal% Fat D12450B from Research Diets Incorporated). Details of these diets 
are listed in table 2.1. The mice were placed on these diets at six weeks of age 
and euthanized after 10 weeks on the special diets.   
Measurement of body weights and fasting blood glucose 
The mice were weighed weekly to monitor changes in bodyweights. To 
assess fasting glucose levels, mice were fasted for 4 hours. Blood was collected 
from the tail tips of the mice. Blood glucose levels were assessed using the 
TRUEtrack® glucose meter (Home Diagnostics Inc.). 
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Measurement of plasma anti-bacterial IgG. 
The ELISA developed by this laboratory was used to measure plasma IgG 
against intestinal bacteria.  96 well flat-bottom ELISA plates (BD-Falcon) were 
coated with 10μg of bacterial protein per well. Plates were incubated overnight at 
4ºC. The wells were washed five times with 1X Tris-Buffered Saline Tween-20 
(TBST). Each washing step was performed for duration of five minutes. The 
plates were then blocked for one hour at room temperature by adding 250µl of 
NAP Blocking reagent diluted 1:2 in 1X TBST to each well. 100µl of plasma 
diluted 1:100 in blocking solution was then added to each well and incubated for 
2 hours at room temperature. The plates were then washed five times with 1X 
Tris-Buffered Saline Tween-20 (TBST). Bound IgG was detected by adding 
100µl/well of alkaline phosphatase-conjugated anti-mouse IgG (Fc specific) from 
Sigma-Aldrich diluted 1:5000 in blocking buffer for 1 hour. The plates were then 
washed five times with 1X Tris-Buffered Saline Tween-20 (TBST).  50µl/well of p-
nitrophenyl phosphate (pNPP) from Sigma-Aldrich) was added, and the color 
reaction was stopped with 2M sulfuric acid. Absorbance values were read at 
optical density 405nm (A405) in a Bio-Rad microplate reader. 
Processing of samples. 
Mice were humanely euthanized using carbon dioxide followed by cervical 
dislocation. Blood was immediately collected by cardiac puncture and placed into 
EDTA containing eppendorf tubes that had been kept on ice. The majority of 
blood obtained was immediately centrifuged at 8,000 rpm for 10 minutes. The 
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plasma was collected and stored at -82°C. The remaining whole blood fractions 
were used to characterize the blood cell types present by hematological analysis.  
Plasma TNF-α measurements. 
To assess the levels of circulating TNF-α we utilized the MILLIPLEX® 
Mouse Cytokine Kit (from Millipore Catalog # MPXMYCTO-70K). The data was 
read in a Bio-Plex® 200 system (BIO-RAD). 
Hematological analysis. 
Subsequent to euthanasia approximately 50µl of whole blood was 
collected from the mice by cardiac puncture. The tubes containing the whole 
blood was briefly rocked. The whole blood was then analyzed using a 
HEMAVET® 950 FS Multispecies Hematology Systems (Drew Scientific Inc.). 
This is a device which gives comprehensive hematology profiles using 20 µL of 
whole blood from different animals including mice. The hematology profiles given 
are for both leukocytes and erythrocytes.  
The leukocyte parameters given are white blood cell count, absolute 
number and percentage of neutrophils, absolute number and percentage of 
lymphocyte, absolute number and percentage of monocyte, absolute number and 
percentage of eosinophil, and absolute number and percentage of basophil. The 
erythrocyte parameters given are red blood cell count, hemoglobin, hematocrit, 
mean cell volume, mean corpuscular hemoglobin concentration and red cell 
distribution width. Additionally thrombocyte parameters including platelet counts 
and mean platelet volume are given. 
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Measuring plasma IgG against intestinal bacteria.  
Cultures of E. coli Nissle 1917, Bacteroides thetaiotaomicron and 
Lactobacilus acidophilus were kindly provided by Dr. Charlotte Kaetzel 
(Department of Microbiology, Immunology and Molecular Genetics, University of 
Kentucky). These bacteria had been obtained from the American Type Culture 
Collection (ATCC). Proteins were extracted from E. coli Nissle 1917, Bacteroides 
thetaiotaomicron and Lactobacilus acidophilus as well as the LF82 strain of E. 
coli. The ELISA developed by this laboratory was used to measure plasma IgG 
against these intestinal bacteria. Ninety six well flat-bottom ELISA plates (BD-
Falcon) were coated overnight with 100µl of the bacterial protein extracts. 
Plasma from the LFD mice and the HFD mice was diluted 1:100 to quantify IgG 
against E. coli LF82, E. coli Nissle 1917, Bacteroides thetaiotaomicron and 
Lactobacilus acidophilus. 
To determine if inflammation originates in the GI tract.  
RNA was extracted from ileum and colon using using the E.Z.N.A® Total 
RNA Kit. We used the Thermo Scientific NanoDrop 2000 spectrophotometer 
(Thermo Scientific) to measure RNA concentration. The qScript™ cDNA 
Synthesis Kit was used to generate cDNA. We analyzed the intestinal samples 
for expression of inflammatory genes. The genes we examined were Chemokine 
(C-C motif) ligand 5 (CCL5 also known as RANTES), NOD-like receptor family 
pyrin domain containing 6 (NLRP6), IL-18 and thymic stromal lymphopoietin 
(TSLP) expression using a BIORAD CFX96™ Real Time PCR detection system. 
Gene expression was normalized to Glyceraldehyde 3-phosphate 
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dehydrogenase (GAPDH). The reason for examining NLRP6, IL-8 and CCL5 was 
due to their association with inflammatory responses against intestinal bacteria. 
TSLP was examined since TSLP secreted by the intestinal epithelial cells 
promote tolerance to the intestinal bacteria. The primer sequences used for RT-
PCR analysis of these genes are listed in table 2.4. 
HUMAN STUDIES. 
 
Human plasma samples from a Centers of Biomedical Research 
Excellence (COBRE) pilot study “The influence of SAA and CETP activity on 
HDL remodeling during active weight loss” were kindly provided by Dr. Anisa 
Jahangiri. All of the plasma samples obtained from this study were from obese 
patients (BMI ≥ 30). One group of the obese patients had not been diagnosed 
with type 2 diabetics (obese non-diabetics). The other group of obese patients 
had been diagnosed with type 2 diabetes (fasting plasma glucose ≥126 mg/dl). 
Plasma samples from non-diabetic individuals with BMI values in the healthy 
range (BMI ≥ 20 and ≤25) were obtained commercially from Biospecialty Corp. 
(Colmar, PA, USA) for experimental controls. The study was approved by the 
Institutional Review Board (IRB) at the University of Kentucky. Plasma samples 
were stored at -82°C and not subjected to freeze thaw cycles. Details of the 
human plasma donors are given in table 2.2. 
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Western Blot Analysis of human plasma. 
Proteins were then extracted from Escherichia coli and separated on 
NuPAGE® 4-12% Bis Tris Gels as previously described. After the proteins were 
transferred to PVDF membranes, the membranes were placed in non-animal 
protein (NAP) blocking solution diluted 1:2 with 1X femto-TBST. The PVDF 
membranes were sliced into individual strips and incubated with plasma samples 
from ten healthy control individuals as well as six obese non-diabetics and six 
obese diabetics.  
The plasma samples were diluted 1:400 in the blocking solution and 
incubated overnight at 4°C. The strips were then washed 5 times in 1X TBST. 
The membrane strips were incubated in anti-human IgG (Fc specific)-Peroxidase 
antibody diluted 1:5000 in the blocking solution for one hour. The membrane 
strips were washed five times in 1X TBST. ECL Western Blotting Substrate was 
simultaneously added to each of the membrane strips and imaging was 
performed on the Kodak Image Station 440.  
Measurement of anti-bacterial IgG. 
IgG against E. coli Nissle 1917, Bacteroides thetaiotaomicron and 
Lactobacilus acidophilus and E. coli LF82 was measured in plasma samples from 
the lean healthy controls, obese non-diabetics and obese diabetics by lab 
developed ELISA. Human plasma samples were diluted 1:400 in blocking 
solution.  
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Bound IgG was detected by adding 100µl/well of alkaline phosphatase-
conjugated anti-human IgG (Fc specific) from Sigma-Aldrich diluted 1:5000 in 
blocking buffer for 1 hour. 50µl/well of p-nitrophenyl phosphate (pNPP) from 
Sigma-Aldrich) was added, and the color reaction was stopped with 2M sulfuric 
acid. Absorbance values were read at optical density 405nm (A405) in a Bio-Rad 
microplate reader. 
Measurement of TNF-α 
Plasma TNF-α was measured in the obese non-diabetics and the obese-
diabetics using the Human TNF-alpha High Sensitivity ELISA from eBioscience 
(BMS223HS; sensitivity 0.13 pg/mL). 50 μl of human plasma was added in 
duplicate. The human plasma samples were diluted in 50 μl of sample diluent. 
Statistical analyses. 
Results were expressed as mean ± S.E.M and were analyzed with 
GraphPad Prism v5.04. Groups were compared with unpaired Student’s t-tests 
and ANOVA and Bonferroni’s post-hoc analysis. Statistical significance was 
assumed when p<0.05.  
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LIST OF TABLES. 
Table 2.1: Details of the rodent diets. 
Diet % kcal 
Protein 
% kcal 
Carbohydrate 
% kcal 
Fat 
Teklad Global 18% Protein 
Rodent Diet 2918 
24 58 18 
 Research Diets Inc. Low fat 
diet (LFD) D12450B 
20 70 10 
Research Diets Inc. High fat 
diet (HFD) D12492 
20 20 60 
Research Diets Inc.  
Western Diet D12079B 
17 43 41 
 
 
Table 2.2: Human plasma sample details. 
Patient 
group 
Sample 
size (n) 
BMI Gender 
ratio 
Lean, 
healthy 
10 24.8 ± 3.0 
 
1♀, 9♂ 
Obese 
non-diabetics 
16 41.1 ± 10.4 
 
7♀, 9♂ 
 
Obese 
diabetics 
16 40.6 ± 7.1 
 
7♀, 9♂ 
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Table 2.3: List of primer sequences used for genotyping. 
Primer Sequence 
Pigr WT A GAACTCTTGTCTTTTGTCTCC 
Pigr WT B CTCGCCTGAATACTCCTT 
Pigr KO A GAACTCTTGTCTTTTGTCTCC 
Pigr KO B TCCAGACTGCCTTGGGAAA 
 
Table 2.4: List of real time PCR primer sequences. 
Primer Sequence 
mGAPDH-F CCAGGTTGTCTCCTGCGACTT 
mGAPDH-R CCTGTTGCTGTAGCCGTATTCA 
mTNFa-F CCCTCACACTCAGATCATCTTCT 
mTNFa-R GCTACGACGTGGGCTACAG 
mIL-6-F AAGAGCCGGAAATCCACGAAA 
mIL-6-R TCTTGGCGTTACAGAGGATCA 
mNLRP6f1 TCTCTCCGTGTCAGCGTTCA 
mNLRP6r1 CGGAAGAGCCGATTAAAAGTGT 
mIL-18-F GACTCTTGCGTCAACTTCAAGG 
mIL-18-R CAGGCTGTCTTTTGTCAACGA 
mCCL5-F TTTGCCTACCTCTCCCTCG 
mCCL5-R CGACTGCAAGATTGGAGCACT 
mTSLP-F ACGGATGGGGCTAACTTACAA 
mTSLP- R ACTCCTCGATTTGCTCGAACT 
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RESULTS  
Preliminary mouse studies. 
HFD mice have higher plasma IgG against invasive intestinal 
bacteria. 
To investigate whether a high fat diet is associated with systemic immune 
responses against the intestinal bacteria, we performed Western Blots to 
determine whether there is an association between long term (10 weeks) 
HFD consumption and immunoglobulin G (IgG) against invasive intestinal 
bacteria. Our data showed that the plasma of the mice on the HFD had 
higher levels of IgG against antigens from invasive intestinal bacteria than 
the mice on the LFD (Figure 2.1). 
HFD mice have higher anti-bacterial IgG. 
Western blot analysis was then performed to compare plasma IgG against 
the antigens from the cecums of LFD mice. Plasma IgG against the 
antigens present in the cecum were low in each of the LFD mice (left 
panel Figure 2.2). Plasma IgG against the antigens present in the cecum 
was high in each of the individual HFD mice.  
 
 
 
42 
 
Figure 2.1  Anti-E. coli LF82 IgG 
 
 
 
  
PVDF membranes with E. coli LF82 protein extracts were cut into 
individual strips. Each strip was incubated in plasma from an individual mouse on 
a LFD (left) and individual mouse on a HFD (right). Plasma was diluted 1:10 in 
blocking reagent. 
Figure 2.2 Anti-bacterial IgG. 
 
Membrane strips were incubated in plasma from individual mice on a LFD 
(left) and individual mice on a HFD (right). Plasma was diluted 1:10 in blocking 
reagent. 
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LONG TERM FEEDING STUDY IN C57BL6 MICE. 
Increased weight gain and fasting blood glucose in HFD mice. 
As expected, HFD fed mice subsequently gained significantly more weight 
over the duration of the study than the mice on the LFD. Six weeks after 
commencing the special diets we observed a statistically significant difference 
between the bodyweights of LFD and HFD mice (Figure 2.3 A). Fasting blood 
glucose was measured using the TRUEtrack® glucose meter. After 10 weeks on 
the special diets, HFD mice had significantly higher fasting blood glucose levels 
(Figure 2.3 B, p<0.05).  
Long term HFD consumption leads to increased plasma TNF-α in 
mice.  
Plasma obtained from mice by cardiac puncture after the 10 week feeding 
regimen was analyzed for total TNF-α by the MILLIPLEX® Mouse Cytokine Kit. 
HFD mice had higher plasma TNF-α than LFD mice. The difference between the 
plasma TNF-α in the HFD mice and the LFD mice was significant (Figure 2.3 C, 
p<0.05).     
Plasma IgG against invasive intestinal bacteria is increased in HFD 
mice.  
HFD mice had significantly higher plasma IgG against protein extracts 
from the LF82 strain of E. coli (Figure 2.4 A). However statistical analysis 
revealed that there were no significant differences between LFD and HFD mice 
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in plasma IgG against E. coli Nissle 1917, Bacteroides thetaiotaomicron and 
Lactobacilus acidophilus (Figures 2.4 B, 2.4 C and 2.4 D).  
Neutrophil percentage is increased in HFD mice. 
The HEMAVET® 950 FS Multispecies Hematology System was used in 
order to measure the inflammatory immune cell subsets. It was observed that the 
HFD mice had a higher percentage of neutrophils compared to LFD mice. 
Statistical analysis revealed that the difference between both groups was 
significant (Figure 2.5 A, p < 0.05). Lymphocyte percentage in the HFD mice was 
significantly lower than in the LFD mice (Figure 2.5 B, p < 0.05). No differences 
were observed between the LFD mice and the HFD mice in the percentages of 
the monocytes, eosinophils and basophils.  
Long term HFD consumption promotes intestinal inflammation. 
Real-time quantitative PCR was performed in order to determine whether 
inflammation was present in the GI tract of HFD mice. A variety of pro-
inflammatory genes were analyzed. These included interleukin-18 (IL-18), 
chemokine (C-C motif) ligand 5 (CCL5) and the NOD-like receptor family pyrin 
domain containing 6 (NLRP6). These genes were chosen since they encode 
constituents associated with specialized inflammatory complexes against 
intestinal bacteria referred to as inflammosomes. The ileum and colon sections 
were of special interest since they harbor the highest densities of intestinal 
bacteria. There were no differences in IL-18 expression in the colon (Figure 2.6 
A). However a trend towards increased CCL5 expression in the ileum was 
observed (Figure 2.6 B, p =0.19). There was also a trend towards increased 
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NLRP6 expression in the ileum of HFD mice (Figure 2.6 C, p = 0.1154). Thymic 
stromal lymphopoietin (TSLP) expression was measured to determine whether 
tolerance to the intestinal bacteria was impaired by long term HFD consumption. 
TSLP is secreted by the intestinal epithelial cells (IECs) to prevent the dendritic 
cells from promoting inflammatory responses. A trend towards decreased TSLP 
expression in the colon of HFD mice was observed (Figure 2.6 D, p = 0.1857). 
Collectively the trend towards increased inflammation and decreased tolerance 
provides evidence that the systemic inflammation observed in HFD mice 
originates in the GI tract.  
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Figure 2.3  Comparison of LFD mice and HFD mice during a long time 
feeding study 
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(A) HFD mice gained significantly more weight than LFD mice. (B) After 
ten weeks the fasting blood glucose levels in HFD mice was significantly higher 
than in LFD mice. (C) Plasma TNF-α is higher in HFD mice than in LFD mice. * 
indicates that p < 0.05 
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Figure 2.4: The effect of long term HFD consumption on plasma IgG 
against different intestinal bacteria in C57BL6 mice.  
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(A) HFD mice have increased plasma anti-E. coli LF82 IgG (B) There is no 
difference between HFD mice and LFD mice in plasma IgG against protein 
extracts from EcN (C) There is no difference between HFD mice and LFD mice in 
plasma IgG against L. acidophilus (D) No effect of HFD on plasma IgG against  
B. thetaiotaomicron  * Indicates p < 0.05. For both groups n = 6. Plasma dilutions 
were 1:100.  
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Figure 2.5. Hematological analysis of LFD mice and HFD mice 
 
 
 
 
 
 
 
 
 
 
 
 
 (A) Neutrophil percentage is increased in HFD mice compared to LFD 
mice. (B) Lymphocyte percentage is decreased in HFD mice. (C) No differences 
in monocyte percentage. (D) No differences in eosinophil percentage (E) No 
differences in basophil percentage * indicates that p < 0.05, significant.  
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Figure 2.6 RT-PCR analysis of the ileums and colons of LFD mice 
and HFD mice. 
 
 (A) There was no difference in IL-18 expression in the colon of LFD mice 
and HFD mice. (B) There was a trend towards increased CCL5 expression in the 
ileum of HFD mice compared to LFD mice (p =0.19) (C) There was a trend 
towards increased NLRP6 expression in the ileum in HFD mice (p = 0.1154). (D) 
There was a trend towards decreased TSLP expression in the colon in HFD mice 
(p = 0.1857) 
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HUMAN STUDIES 
Obesity is associated with increased anti-E. coli LF82 IgG. 
Plasma IgG against protein extracts from the LF82 strain of E. coli was 
low in all of the lean healthy controls. Plasma anti-E. coli IgG was high in all of 
the obese subjects. Obese diabetics had higher plasma IgG against protein 
extracts from the LF82 strain of E. coli IgG than the obese non-diabetics (Figure 
2.7).  
Figure 2.7: Western Blot Analysis of plasma from human test subjects 
 
Membranes were cut into individual strips and incubated in 1:400 dilutions 
of human plasma. Left: strips blotted in plasma samples taken from lean health 
controls. Center: strips blotted in plasma from obese non-diabetics. Right: strips 
blotted in plasma obtained from obese diabetics. 
IgG against E. coli LF82 extracts is increased in obese diabetics.  
Obese diabetics had significantly higher plasma IgG against protein 
extracts from the LF82 strain of E. coli than the lean healthy controls (Figure 2.8 
A). However, there were no differences in plasma IgG against E. coli Nissle 
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1917, Bacteroides thetaiotaomicron and Lactobacilus acidophilus between the 
lean healthy controls, the obese non-diabetics and the obese-diabetics (Figures 
2.8 B, 2.8 C and 2.8 D).   
Figure 2.8 Plasma IgG against different intestinal bacteria human subjects 
 
For each obese group n =16, healthy lean controls n=10 (A) Diabetics 
have significantly increased anti-E. coli LF82 IgG compared to lean controls (B) 
No differences in IgG against EcN (C) No differences in IgG against L. 
acidophilus (D) No difference in plasma IgG against  B. thetaiotaomicron * 
indicates p <0.05. Plasma dilutions of 1:400 were used.  
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Obese diabetics have higher plasma TNF-α than obese non-
diabetics.  
We observed that plasma TNF-α was twofold higher in obese diabetics 
than obese non-diabetics. Statistical analysis revealed that the difference in 
plasma TNF-α in the obese diabetics and the obese non-diabetics was highly 
significant (Figure 2.9 A, p<0.01).  
Human plasma TNF-α correlates with IgG against the LF82 strain of 
E. coli. 
To further investigate the relationship between IgG against E. coli LF82 
and plasma TNF-α, we investigated whether a correlation existed between both 
parameters.  We observed that there was a statistically significant correlation 
between TNF-α levels and plasma IgG against the protein extracts from the E. 
coli LF-82 strain (Figure 2.9 B).  
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Figure 2.9 Analysis of plasma TNF-α in obese human subjects 
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DISCUSSION 
PRELIMINARY MOUSE STUDIES: HFD mice have higher plasma IgG 
against invasive intestinal bacteria. 
These studies were commenced in March 2010. By that time there was 
accumulating evidence that the intestinal bacteria in conjunction with long term 
consumption of a high fat diet played a role in the development of systemic 
inflammation and insulin resistance. Our research group hypothesized that long 
term consumption of a high fat diet might cause a loss of systemic immune 
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ignorance to the intestinal bacteria. We postulated that long term HFD 
consumption would result in increased systemic immune responses to the 
intestinal bacteria. To do this we decided to look at systemic immune responses 
against bacteria found exclusively in the GI tract.  
The intestinal bacteria are poorly characterized. We chose to measure 
plasma IgG against the LF82 strain of E. coli which was isolated from an ileal 
lesion of a Crohn’s Disease patient [150].  E. coli LF82 is designated as an 
adherent invasive E. coli strain (AIEC strain). Invasive strains are characterized 
by their ability to enter epithelial cells and subsequently survive and replicate 
[151, 152]. E. coli LF82 invades a number of epithelial cell lines including Caco-2, 
Intestine-407, and HCT-8 cells [153]. E. coli LF82 induces altered cytoskeletal 
arrangements in epithelial cells which leads to its uptake by endocytic vacuoles. 
This bacterial strain is more prevalent in the lesions of Crohn’s disease patients 
than in control patients without inflammatory bowel disease [154].  It should be 
emphasized that this bacterial strain is not present in the GI tract of mice. 
However, since it is an adherent and invasive strain, there may be antigens that 
are shared between this bacterial strain and uncharacterized invasive bacterial 
strains.  
Our pilot western blot analysis of the plasma of LFD and HFD mice 
revealed drastic differences between the two groups. The plasma from HFD mice 
had higher levels of IgG against invasive intestinal bacteria than the mice on the 
LFD. Plasma IgG against invasive intestinal bacteria very low in all four individual 
LFD mice (Figure 3).  The systemic immune system is oblivious to the presence 
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of the immense bacterial load of the GI tract. This is essential since the intestinal 
bacteria play important roles in vitamin synthesis and contribute to the overall 
health of the host individual.  
The higher levels of plasma IgG against invasive intestinal bacteria in HFD 
mice suggested that these mice had lost systemic ‘ignorance’ to the bacteria in 
the GI tract. IgG is produced in response to the presence of antigens in the 
systemic circulation. This may lead to triggering of the systemic immune 
response against these intestinal bacterial pathogens, resulting in increased IgG 
the amount of antigenic material present in the systemic circulation. Therefore 
the higher plasma IgG against intestinal bacteria in HFD mice is indicative of a 
loss of systemic immune ignorance to invasive intestinal bacteria. 
HFD mice have higher anti-bacterial IgG  
As it has been previously mentioned, the GI tract contains at least 500 
bacterial species. Although our finding that higher levels of anti- E. coli IgG in the 
plasma of HFD mice suggested that these mice had lost systemic ‘ignorance’ to 
the bacteria in the GI tract, we needed to establish whether there were higher 
levels of IgG against other bacterial species in the plasma of HFD mice.  
However, this aim was complicated by two major factors. The first was the 
poor characterization of the composition of the intestinal bacteria. Additionally, 
most intestinal bacterial species are anaerobic. This makes the culturing of 
intestinal bacteria challenging. To overcome these problems cecal extracts were 
prepared. The cecum is a pouch shaped structure situated between the ileum 
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and the colon. It is situated in a region of the GI tract where bacterial population 
density is extremely high. It is therefore a reservoir of intestinal bacteria.  
HFD mice had higher levels of plasma IgG against the antigenic contents 
of the cecum compared to the LFD control group (Figure 2.2). This further 
confirmed that HFD consumption is associated with a loss of systemic immune 
ignorance to the intestinal bacteria. This is because the systemic immune system 
is theoretically supposed to be oblivious to the contents of the cecum. 
Furthermore these findings strengthened our hypothesis since IgG against the 
intestinal bacteria of mice was measured. On the other hand, the LFD controls 
had low levels of IgG against the cecal contents. This may be due to the fact that 
these mice have not experienced any significant translocation of the intestinal 
bacteria into the systemic circulation. As a result, the levels of IgG against the 
antigenic components of the cecum are significantly much lower in the LFD 
controls than the HFD fed mice. 
Results from long term feeding study in C57BL6 mice 
The preliminary studies resulted in the observation that mice fed a high fat 
diet (Rodent Diets with 60 kcal% Fat D12492 from Research Diets Incorporated) 
for 10 weeks had elevated plasma anti-E. coli LF82 IgG. Although these findings 
were novel, they offered only a narrow range of interpretation. This is because 
the only parameter that had been examined thus far was plasma anti-E. coli 
LF82 IgG in relation to high fat diet consumption. To gain greater insight into the 
effects of long term HFD consumption on the systemic immune system a long 
term (ten week) feeding study was performed using C57BL6 mice.  
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Two parameters were used to define the end point of the study (i.e. the 
point at which the mice would be euthanized). These were body weight and 
fasting blood glucose. As expected, C57BL6 mice fed a HFD (60% calories from 
fat) gained significantly more weight than the mice fed a LFD (10% calories from 
fat), with bodyweights diverging significantly six weeks into the study (Figure 2.3 
A). However, weight gain by itself is not an accurate indicator of the development 
of elevated fasting blood glucose. The mice were euthanized once a significant 
difference in fasting blood glucose levels was observed. Based on the proposed 
hypothesis a significant elevation in fasting blood glucose would be observed 
subsequent to systemic inflammation and bacterial translocation. 
After 10 weeks the fasting blood glucose levels of the HFD mice were 
higher than the LFD mice (Figure 2.3 B). Statistical analysis revealed that these 
differences were significant (p<0.05) and it was at this point the study was 
terminated. The mice were euthanized and we were able to collect samples to 
evaluate a wide range of parameters.  
Long term HFD consumption leads to increased plasma TNF-α in 
mice.  
HFD mice had elevated plasma IgG against invasive intestinal bacteria. 
Previous studies have linked the IgG response to certain bacterial species to 
disease severity [155]. This is because cross-linking of FcγRs leads to 
inflammation [156, 157]. However, plasma IgG levels alone cannot be used to 
determine whether there is increased systemic inflammation. TNF-α is a widely 
used marker of inflammation. Since the proposed hypothesis states that the 
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immune responses to the intestinal bacteria lead to systemic inflammation, TNF-
α was measured in LFD mice and HFD mice. Statistical analysis revealed that 
the plasma TNF-α in the HFD mice was higher than in the LFD mice (Figure 2.3 
C; p <0.05). These findings strengthened the hypothesis that long term HFD 
consumption leads to systemic inflammatory immune responses being mounted 
against the bacterial antigens present in the lumen of the GI tract.   
A possible explanation for the increased plasma TNF-α could be the 
increase in intestinal bacteria crossing the intestinal epithelial barrier. This could 
lead to immune responses being mounted by the B lymphocytes. The B 
lymphocytes produce IgG which bind to the antigens present on the surface of 
the intestinal bacteria. It is possible that the increase in systemic IgG against 
intestinal bacteria results in increased FcγR crosslinking. This in turn leads to the 
release of TNF-α.   
Plasma IgG against invasive intestinal bacteria is increased in HFD 
mice.  
HFD mice had higher plasma IgG against invasive intestinal bacteria than 
LFD mice (Figure 2.4 A). However, there were no significant differences in 
plasma IgG against protein extracts from E. coli Nissle 1917, Bacteroides 
thetaiotaomicron and Lactobacilus acidophilus in HFD and LFD mice (Figures 2.4 
B, 2.4 C and 2.4 D). As it has been previously stated the systemic immune cells 
are naïve to the presence of the intestinal bacteria. This feeding study resulted in 
increased IgG against invasive intestinal bacteria in the HFD mice. These results 
further support the proposal that long term HFD consumption is associated with 
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increased IgG against antigens that are usually confined to the lumen of the GI 
tract.  IgG is produced as a consequence of the B lymphocytes detecting the 
presence of a particular antigen. Thus the elevated IgG against invasive 
intestinal bacteria in HFD mice was possibly due to the fact that that the B 
lymphocytes were no longer oblivious to these antigens. A possible explanation 
for this is that long term HFD consumption promotes entry of the bacteria present 
in the lumen of the GI tract into the systemic circulation. This triggers systemic 
immune responses including IgG production. 
Neutrophil percentage is increased in HFD mice. 
A variety of immune cells participate in inflammatory reactions. Since the 
sample number for the mouse studies (n = 6 for each group) was relatively small, 
further evidence was needed that long term HFD consumption results in 
inflammatory immune responses. The HEMAVET® 950 FS Multispecies 
Hematology Systems is useful in characterizing the various blood cell types 
present. After the ten week feeding study was completed, and the mice were 
euthanized we characterized the various immune cells present in whole blood 
fractions. The neutrophil percentage in the blood of the HFD mice was 
significantly increased compared to the LFD mice (Figure 2.5 A, p <0.0001). The 
increase in neutrophil percentage in HFD mice provides further evidence that 
long term HFD consumption leads to increased systemic inflammatory immune 
responses against the intestinal bacteria. Neutrophils are present in the initial 
phase of inflammation [158]. They ingest infectious microbes and eliminate them. 
The intracellular destruction of microbes by neutrophils is mediated by their 
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cytoplasmic granules via superoxide production as well as the proteases 
elastase and cathepsin G [159].  
A possible explanation for the increase in neutrophil percentage may be 
the increased plasma IgG against invasive intestinal bacteria in the HFD mice.  
Since FcγRs are expressed on the surface of neutrophils, there may be 
increased cross-linking of FcγRs with the Fc domains of the IgG against the 
intestinal bacterial antigens [160]. No significant differences were noted in 
monocyte percentage, basophil percentage or eosinophil percentage in the blood 
of HFD mice and LFD mice (Figures 2.5 C, 2.5 D and 2.5 E). This was not 
surprising since basophils are usually produced in response to infections by 
helminthes [161]. They are also usually associated with allergens and are 
associated with allergic reactions. Eosinophil percentage did not differ between 
the LFD and HFD mice. Eosinophils protect against parasitic infections [162]. Our 
discovery that long term consumption of a high fat diet specifically increases the 
percentage of neutrophils was significant. The increase in neutrophil percentage 
was observed along with increased plasma IgG against invasive intestinal 
bacteria, providing further evidence that the systemic immune responses against 
intestinal bacteria are inflammatory.  
Long term HFD consumption promotes intestinal inflammation. 
Real time PCR (RT-PCR) analysis was performed in order to determine 
whether the systemic inflammation we observed originated in the GI tract. It has 
been traditionally thought that the higher levels of inflammatory cytokines 
associated with high fat diet consumption originate in the adipose tissue [163]. 
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However, there is a growing body of evidence which suggests that inflammation 
resulting from long term HFD consumption may originate in the gastrointestinal 
(GI) tract [65]. For example, it has been reported that long term HFD 
consumption may alter the bacterial composition of the GI tract [68]. Furthermore 
Ding et al observed that conventionally raised (CONV) mice consuming a high fat 
diet experienced intestinal inflammation [70]. By contrast GF mice fed a high fat 
diet did not exhibit intestinal inflammation.  
Therefore it was crucial to determine whether the HFD mice experienced 
intestinal inflammation. The ileum and colon sections of the GI tract were 
analyzed for intestinal inflammation. This is because these regions of the GI tract 
harbor the largest bacterial populations. Different pro-inflammatory markers were 
measured. These were the NOD-like receptor family pyrin domain containing 6 
(NLRP6), Chemokine (C-C motif) ligand 5 (CCL5 also known as RANTES) and 
IL-18. RT-PCR revealed a trend towards increased NLRP6 expression in the 
ileum HFD mice (LFD 1.000 ± 0.2285, HFD 16.90 ± 9.220, p = 0.1154). NLRP6 is 
thought to play a role in inflammation via the activation of NF-κB [164]. Although 
the difference between the LFD mice and the HFD mice was not statistically 
significant, this was probably due to the relatively small sample size (where n = 
6) for each group. Although intestinal IL-18 did not differ between LFD and HFD 
mice, there was a trend towards increased CCL5 in the ileum of the HFD mice 
(LFD 1.136 ± 0.1660, HFD 2.444 ± 1.001, p = 0.1900). CCL5 plays a role in 
inflammation by recruiting macrophages [165]. Thus the trend towards increased 
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CCL5 expression in the GI tract supports the idea that the systemic inflammation 
observed originates from the GI tract.  
Thymic stromal lymphopoietin (TSLP) expression was also measured. 
TSLP is constitutively secreted by the intestinal epithelial cells (IECs). The IECs 
secrete TSLP which prevents the dendritic cells (DCs) from promoting 
inflammatory immune responses. The DCs sample antigens and present them to 
T lymphocytes. RT-PCR showed a trend towards reduction of TSLP expression 
in the colon of HFD mice compared to the LFD controls (LFD 6.867 ± 4.469, HFD 
0.5141 ± 0.1141, p = 0.1857). Since TSLP is crucial to preventing intestinal 
inflammation, the trend towards decreased TSLP expression provides further 
evidence that the systemic inflammation may have originated in the GI tract.  
HUMAN STUDIES 
We decided to investigate whether long term consumption of a high fat 
diet is associated with increased plasma IgG against invasive intestinal bacteria 
in humans. We made the assumption that humans who had consumed a high fat 
diet over a long time period would have body mass index values in the 
overweight and obese range (≥ 25). When we performed Western Blot analysis 
we observed what appeared to be striking differences between the three groups.  
Plasma IgG against protein extracts from the LF82 strain of E. coli was lowest in 
the lean healthy control group. Plasma anti-E. coli LF82 IgG was higher in the 
plasma of the obese individuals. Notably there appeared to be a difference in 
plasma anti-E. coli LF82 IgG between the non-diabetic individuals and diabetic 
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patients. The obese diabetics had higher plasma anti-E. coli LF82 IgG than their 
non-diabetic counterparts.  
These findings provided further evidence that long term HFD consumption 
is associated with a loss of systemic immune ignorance to the intestinal bacteria. 
As it has been previously stated, the LF82 strain of E. coli is only known to reside 
in the GI tract. The low levels of plasma anti-E. coli LF82 IgG in the lean healthy 
controls was not surprising. The systemic immune system is ‘ignorant’ to the 
existence of the immense bacterial load of the GI tract. This is important for 
minimizing potentially harmful inflammatory immune responses against the 
immense reservoir of antigenic material in the GI tract. However, what was 
particularly striking was the difference in anti-E. coli LF82 IgG in obese non-
diabetics and obese diabetics. Anti-E. coli LF82 IgG was higher in obese 
diabetics than in obese non-diabetics. This finding suggested that the systemic 
immune responses against intestinal bacterial pathogens may be linked to insulin 
resistance and the development of type 2 diabetes.   
IgG against invasive intestinal bacteria is increased in obese 
diabetics.  
Quantifying plasma IgG against the intestinal bacteria was crucial in 
determining whether the apparent differences observed in our Western Blot 
analyses had statistical significance. Furthermore, in order to determine whether 
any quantitative relationships existed between IgG against the intestinal bacteria 
and inflammatory cytokine levels we needed a reliable quantitative assay. As a 
consequence, we developed our own laboratory made ELISA by coating 96 well 
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flat-bottom ELISA plates with soluble protein extracts from E. coli Nissle 1917, 
Bacteroides thetaiotaomicron and Lactobacilus acidophilus and E. coli LF82 
dissolved in a carbonate coating buffer. The difference between the plasma anti-
E. coli LF82 IgG in lean controls and obese diabetics was significant (p = 
0.0107). The lean controls had the lowest levels of plasma IgG against invasive 
intestinal bacteria. The low plasma anti- E. coli LF82 IgG in lean healthy controls 
is probably due to the fact that the immune system these individuals maintain a 
state of ignorance to the intestinal bacteria.  
What was particularly interesting was that while obese diabetics had 
higher plasma anti- E. coli LF82 IgG than the lean controls, there was no 
difference in plasma anti-E. coli LF82 in obese non-diabetic individuals compared 
to the lean healthy controls. The obese non-diabetics had body mass index 
values that were statistically equivalent to the obese diabetic patients. This led us 
to hypothesize that plasma IgG against the intestinal bacteria may be related to 
the transition from a non-diabetic state to a diabetic state.  
Immunoglobulin G is the major immunoglobulin subclass produced in 
response to the presence of antigens in the systemic circulation. The IgG 
response to certain bacterial species has also been correlated with disease 
severity [166]. IgG is comprised of two identical heavy chains and two identical 
light chains, arranged in a Y shaped configuration. The IgG molecule is 
comprised of an antigen binding fragment (Fab) domain and a crystalizeable 
fragment (Fc) domain. Receptors for the Fc domain of IgG (FcγRs) are located 
on the surface of immune cells. Inflammation results from the cross-linking of 
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FcγRs. It is possible that the increased IgG against intestinal bacteria could have 
resulted in increased FcγR cross-linking. This in turn could have led to increased 
systemic inflammation. Uncontrolled systemic inflammation can adversely affect 
insulin signaling pathways, leading to insulin resistance and the development of 
type 2 diabetes.   
Human plasma TNF-α correlates with IgG against the LF82 strain of 
E. coli. 
Statistical analysis was performed to determine whether there was a 
correlation between anti-E. coli LF82 IgG and TNF-α. This was done to establish 
a more definitive link between the immune responses against the intestinal 
bacteria and inflammatory markers. The sample size in the animal study (n=6 for 
each group) was insufficient to perform a correlation analysis. 
 The correlation analysis was performed using the human plasma 
samples. This is because the sample size for human subjects was larger (n=16 
for each group, 32 in total). There were two groups of obese subjects: obese 
non-diabetics and obese diabetics. Both groups had mean BMI values that were 
statistically equivalent (obese non-diabetics mean BMI 41.1 ± 10.4 versus obese 
diabetics mean BMI 40.6 ± 7.1). As a consequence, a discrepancy in adiposity 
could be ruled out. It was observed that there was a statistical correlation 
between anti-E. coli LF82 IgG and plasma TNF-α in the human subjects. The 
correlation between anti-E. coli LF82 IgG and TNF-α is further evidence that the 
systemic immune responses to the intestinal bacterial antigens are associated 
with inflammation. It is possible that the increase in IgG against intestinal 
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antigens promotes cross-linking of FcγRs, which in turn causes the release of 
pro-inflammatory markers such as TNF-α [167].  
The correlation between anti-E. coli LF82 IgG and plasma TNF-α linked 
inflammation to the immune responses against intestinal antigens. If systemic 
inflammation was linked to the development of type 2 diabetes, then theoretically 
the obese diabetics would have higher levels of plasma TNF-α. To determine 
whether this was the case, TNF-α in the human plasma samples was measured 
by ELISA. It was observed that there was a difference in plasma TNF-α between 
both groups of obese subjects. TNF-α in the obese diabetics was significantly 
higher than in the obese non-diabetics. This finding provides further evidence 
that the inflammation resulting from intestinal bacterial antigens may lead to the 
development of type 2 diabetes. It is possible that insulin signaling could have 
been adversely affected by the presence of high levels of plasma TNF-α. 
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CHAPTER 3 HIGH FAT DIET CONSUMPTION AND INTESTINAL IMMUNITY. 
INTRODUCTION 
Immunoglobulin A (IgA) actively secreted into the GI tract minimizes the 
adherence of bacteria to the intestinal epithelium. In our initial studies we 
observed an association between long term consumption of a HFD and elevated 
plasma anti-E. coli LF82 IgG. As a consequence, we investigated whether long 
term HFD consumption impairs IgA secretion into the lumen of the GI tract. To do 
this we measured fecal IgA in mice fed a LFD (10% calories from fat) and mice 
fed a HFD (60% calories from fat). Plasma IgA levels were measured in LFD and 
HFD mice. IgA is the second most abundant immunoglobulin in the plasma. 
Plasma IgA neutralizes antigens and suppresses inflammatory effects of 
antibody dependent cellular toxicity [168]. Furthermore, small quantities of 
plasma IgA enter the intestinal mucosal secretions by paracellular diffusion  
[131].  
A goal of this study was to assess whether the absence of the active 
secretion of IgA into the lumen of the GI tract by the pIgR is a predisposing factor 
for development of metabolic syndrome. The polymeric immunoglobulin receptor 
(pIgR) actively secretes polymeric immunoglobulins into the lumen of the GI tract. 
An estimated 3 grams of IgA are secreted daily. Since this involves considerable 
energy expenditure, we reasoned that this specialized secretory mechanism 
plays a role in preventing adherence of the commensal bacteria to the intestinal 
epithelial cells. 
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. Our previous studies had shown that long term HFD consumption was 
associated with increased IgG against adherent invasive intestinal bacteria. We 
postulated that perhaps mice lacking pIgR (pIgR KO mice) might be more 
susceptible to intestinal epithelial cell adherence and invasion. This could result 
in inflammatory immune responses being mounted against the resident gut 
bacteria. To determine whether this was the case, pIgR knockout mice and 
C57BL6 wild type littermate controls were placed on a Western Diet (Rodent 
Diets with 41 kcal% Fat, 43 kcal% Carbohydrate and 17 kcal% Protein).  A 
Western Diet feeding regimen was chosen since the Western Diet is 
representative of the diets that are associated with metabolic disorders in 
humans.  
The human plasma samples were also analyzed by total IgA ELISA. This 
was done in order to determine whether plasma IgA levels differed between the 
lean healthy controls, obese non-diabetics and obese diabetics. It was observed 
that plasma IgA differed between the three groups of human subjects. Lean 
controls had the highest levels of plasma IgA. Obese non-diabetics had 
significantly reduced plasma IgA compared to the lean controls. Obese diabetics 
have significantly reduced plasma IgA compared to both obese non-diabetics 
and lean controls. 
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METHODS 
Determining the effect of long term HFD consumption on fecal IgA  
C57BL6 mice aged 6 weeks were divided into two equal groups (n = 6). 
One group was fed a high fat diet (Rodent Diets with 60 kcal% Fat D12492 from 
Research Diets Incorporated). The other group was fed a low fat diet (Rodent 
Diets with 10 kcal% Fat D12450B from Research Diets Incorporated). Details of 
these diets are listed in table 2.1. The mice were placed on the special diets for 
10 weeks.  
Fecal IgA extraction 
Fecal IgA was extracted utilizing a protocol previously employed by 
Ferguson et al [169]. Fecal IgA extraction buffer was prepared utilizing 
phosphate-buffered saline (PBS, pH 7.4), 0.5% Tween® 20 and complete, EDTA-
free protease inhibitor cocktail. The extraction buffer was added to each tube at a 
ratio of 1 ml of buffer to 0.10 g of feces. The samples were manually 
homogenized and the resulting mixtures were vortexed. The resulting fecal 
suspensions were centrifuged at 14,000 rpm for 20 minutes and the supernatants 
were collected for further use. 
Total fecal IgA measurements 
Total fecal IgA was quantified using an ELISA for Mouse IgA from 
MABTECH.  96 well flat-bottom ELISA plates (BD-Falcon) were coated overnight 
with monoclonal anti-IgA antibody diluted 2µg/ml in PBS (pH 7.4). Blocking was 
performed for one hour at room temperature using incubation buffer (PBS with 
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0.05% Tween 20 and 0.1% BSA).  Subsequent to blocking fecal IgA extracts 
were diluted 100X in incubation buffer and added in triplicate. Total IgA was 
detected using anti-IgA-ALP diluted 1:500 in incubation buffer. P-nitrophenyl 
phosphate was then added and the optical density was measured at 405nm 
using a Bio-Rad microplate reader. IgA concentration was divided by the mass of 
fecal pellets to give the quantity of IgA present per gram of feces (IgA/g feces). 
Quantifying total fecal output and food intake. 
To gain an accurate estimate of total fecal IgA production per day total 
daily fecal output was measured in a separate group of C57BL6 mice. C57BL6 
mice were divided into two groups. One group was fed a high fat diet (Rodent 
Diets with 60 kcal% Fat D12492 from Research Diets Incorporated). The other 
group was fed a low fat diet (Rodent Diets with 10 kcal% Fat D12450B from 
Research Diets Incorporated).  
Total fecal output: Mice were placed in a cage with clean bedding, with 
free access to food and water. Fecal pellets were collected at intervals of 24 
hours and weighed.  It should be noted that metabolic cages were available from 
the COCVD PHYSIOLOGIC RESEARCH CORES at the University of Kentucky. 
However, the Eckhardt Laboratory did not have the required protocol approvals 
to measure fecal output in mice using these facilities.    
Quantifying food intake: Mice were given free access to food and water. 
Food was weighed at 24 hour intervals. The weight of food was subtracted from 
the previous weight to give total consumption. This was then divided by the 
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number of mice in the cage to give an estimate of the amount of food consumed 
by each mouse.  
Effect of HFD consumption on plasma IgA. 
The effect of HFD consumption on plasma IgA was assessed in HFD mice 
and LFD mice. Plasma IgA was measured using the ELISA for Mouse IgA. 96 
well flat-bottom ELISA plates (BD-Falcon) were coated overnight with 
monoclonal anti-IgA antibody diluted 2µg/ml in PBS (pH 7.4). Blocking was 
performed for one hour at room temperature using incubation buffer (PBS with 
0.05% Tween 20 containing 0.1% BSA). Subsequent to blocking plasma diluted 
100X in incubation buffer was added in triplicate. Total IgA was detected using 
anti-IgA-ALP diluted 1:500 in incubation buffer. P-nitrophenyl phosphate was 
then added and the optical density was measured at 405nm using a Bio-Rad 
microplate reader.  
To evaluate whether impaired IgA secretion increases the risk of 
developing metabolic syndrome. 
Mice: Six pIgR knockout mice (pIgR KO mice) on a C57BL/6 background 
were kindly donated by Dr. Charlotte Kaetzel (Department of Microbiology, 
Immunology and Molecular Genetics, University of Kentucky). pIgR KO mice are 
unable to actively secrete polymeric IgA into the lumen of the GI tract. This is 
because the third exon of the PIGR locus has been disrupted by the use of a 
targeting vector [170]. For controls we utilized wild type C57BL/6 littermates 
(n=7). Mice were housed three per cage and maintained in a 12h light / dark 
cycle. We allowed the mice to become acclimated to their new environment.  
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When the mice were obtained they were being fed the Teklad Global 18% 
Protein Rodent Diet (hereafter referred to as regular chow diet). Both groups of 
mice were maintained on the regular chow diet for one week after receiving 
them. The reason for doing this was to measure a variety of baseline metabolic 
parameters. The mice were then switched to a high fat, high carbohydrate 
Western Diet (Rodent Diets with 41 kcal% Fat, 43 kcal% Carbohydrate, 17 kcal% 
Protein). Details of the diets are listed in table 2.1. The mice were fed the 
Western Diet for 16 weeks.  
Processing of samples for analysis. 
Mice were euthanized using carbon dioxide. Blood was immediately 
collected by cardiac puncture and placed into EDTA containing eppendorf tubes 
that had been kept on ice. The majority of blood obtained was immediately 
centrifuged at 8,000 rpm for 10 minutes. The plasma was collected and stored at 
-82°C. The remaining blood (whole blood fraction) was used for hematological 
analysis. After mice were euthanized the ileums and colons were harvested. 
Intestinal mucosal scrapings were collected and frozen immediately in liquid 
nitrogen. 
Identification of mice.  
After the mice were obtained they were implanted with IPTT-300 
transponders (Vendor BMDS) for identification. After the mice were euthanized, 
they were identified and tail snips were collected from individual mice. DNA was 
extracted from the tail snips using the Qiagen DNeasy Blood and Tissue kit 
(QIAGEN Catalog# 69504). Polymerase chain reaction (PCR) was then 
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performed using a Perkin Elmer GeneAmp PCR System 9600. The primer 
sequences to detect the Pigr mutant gene (Pigr KO) and the wild type Pigr gene 
(Pigr WT) are listed in table 2.3. 
Body weight and body fat analyses 
pIgR KO mice and the C57BL/6 controls were weighed prior to 
commencing the Western Diet feeding regimen. Once the feeding study was 
started the mice were weighed weekly. EchoMRI™ analysis was performed in 
order to determine whether there were differences in body fat percentage.  
Plasma cytokine analysis  
To assess the levels of circulating inflammatory cytokines we utilized 
MILLIPLEX® Mouse Cytokine Kits (from Millipore). The first kit (Catalog # 
MPXMYCTO-70K) quantified the cytokines IL-1b, IL-6, IL-10 and TNF-α, IL-12, 
IL-7, IL-5 and IL-13 prior to commencing the Western Diet, as well as two and 
sixteen weeks after commencing the Western Diet feeding regimen. The second 
kit used (Catalog # MADPK-71K) measured insulin, resistin, leptin, PAI-1 and 
TNF-α eight and sixteen weeks after commencing the Western Diet feeding 
regimen.  
Hematological analysis. 
50µl of whole blood fractions collected from the mice after euthanasia was 
used. The tubes containing the whole blood was placed on a rocker for 2 
minutes. Samples were then analyzed using a HEMAVET® 950 FS Multispecies 
Hematology Systems (Drew Scientific Inc.).   
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Oral glucose tolerance test (OGTT) 
To assess oral glucose tolerance, mice were fasted for 6 hours. Blood was 
collected from the tail tips of mice and blood glucose levels were recorded using 
the TrueTrack glucose meter (Home Diagnostics Inc). The mice were gavaged 
with a dose of 2.0g/kg glucose. Blood glucose measurements were recorded at 
15, 30, 60, 90 and 120 minutes post-gavage. We performed the OGTT prior to 
commencing the Western Diet feeding and two weeks, ten weeks and sixteen 
weeks after commencing the Western Diet feeding regimen.  
Real time PCR analysis 
We compared the levels of inflammatory markers in the intestinal tissue of 
pIgR KO mice and C57BL6 controls. After mice were euthanized the small 
intestine and colon were harvested. RNA was extracted from intestinal tissues by 
the E.Z.N.A® Total RNA Kit. The RNA was converted into cDNA using the 
qScript™ cDNA Synthesis Kit.  We analyzed the samples for expression of TNF-
α and IL-6 using a BIORAD CFX96™ Real Time PCR detection system. 
Statistical analyses. 
Results were expressed as mean ± S.E.M and were analyzed with 
GraphPad Prism v5.04. Groups were compared with unpaired Student’s t-tests 
and ANOVA and Bonferroni’s post-hoc analysis. Statistical significance was 
assumed when p<0.05. Area under the curve analyses were performed using 
SigmaPlot.  
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ANALYSIS OF HUMAN PLASMA IgA. 
We also measured plasma IgA in humans. Details of the human plasma 
donors are listed in table 2.2. Total plasma IgA in the humans was assessed with 
a Human IgA ELISA kit from MABTECH (3860-1AD-6).  96 well flat-bottom 
ELISA plates (BD-Falcon) were coated overnight with MT57 antibody diluted 
2µg/ml in PBS (pH 7.4). Blocking was performed with incubation buffer and 
human plasma was diluted 400X in incubation buffer and added in triplicate. 
Total IgA present in human plasma was detected by adding a 1000 fold dilution 
of MT20-ALP. P-nitrophenyl phosphate was then added and the optical density 
was measured at 405nm using a Bio-Rad microplate reader.  
RESULTS  
HFD mice have reduced fecal IgA. 
The effect of diet on secretion of IgA into the lumen of the GI tract was 
studied in C57BL6 mice fed a HFD and a LFD. During the first three weeks of the 
study statistical analysis revealed that there were no differences between the 
fecal IgA levels in the LFD mice or the HFD mice. However, by the fourth week of 
the study fecal IgA levels between LFD and HFD mice had diverged significantly. 
The LFD mice had significantly higher fecal IgA than the HFD mice. Higher fecal 
IgA in the LFD mice compared to the HFD mice was observed throughout the 
duration of the feeding study (Figure 3.1 A).  Analysis of the fecal IgA levels in 
the LFD mice and HFD mice revealed that there was an increase in fecal IgA 
over time in the LFD mice. On the other hand, the levels of fecal IgA in the HFD 
mice remained relatively unchanged. Thus the differences noted between fecal 
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IgA in LFD and HFD mice were a consequence of increased fecal IgA in LFD 
mice relative to fecal IgA in HFD mice.  
HFD consumption reduces fecal output.  
In order to obtain a more accurate estimate of fecal IgA output, total fecal 
output was measured. HFD consumption reduced the fecal output in C57BL6 
mice compared to LFD controls. Statistical analysis revealed that this reduction 
was highly significant (Figure 3.1 B, p<0.01). 
Diet does not alter food intake.  
Since the C57BL6 mice were fed different special diets, we wanted to 
investigate whether this led to any changes in food intake. Statistical analysis 
revealed that there were no significant differences in food intake between the 
LFD mice and the HFD mice (Figure 3.1C).  
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Figure 3.1 Effect of diet on fecal IgA. 
 
  
 
 
 
 
 
 
 
 
 
(A) Fecal IgA change over time. No differences in fecal IgA for the first 
three weeks of the study (NS). From week four until the end of the study fecal 
IgA in LFD mice was higher than HFD mice. (B) Fecal output was significantly 
reduced in C57BL6 mice fed a HFD compared to C57BL6 mice fed a LFD (C) No 
difference in food intake in C57BL6 mice fed a HFD compared to C57BL6 mice 
fed a LFD.  * indicates p <0.05.  
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No effect of HFD consumption on plasma IgA.  
Plasma IgA from C57BL6 mice fed special diets (LFD and HFD) for 10 
weeks of was measured by total IgA ELISA. There was no significant difference 
in plasma IgA between HFD mice and LFD mice (Figure 3.2).  
Figure 3.2 The effect of HFD consumption on plasma IgA in C57BL6 
mice. 
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The effect of HFD consumption on plasma IgA in C57BL6 mice. Total 
plasma IgA was measured in HFD mice (n=6) and LFD mice (n=6). Statistical 
analysis revealed that plasma IgA did not differ between LFD mice and HFD 
mice.  
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To assess whether impaired IgA secretion into the lumen of the GI 
tract is a predisposing factor for development of metabolic syndrome. 
pIgR KO mice have higher plasma IgA. 
To investigate whether long term consumption of a high-fat, high-
carbohydrate Western Diet would affect plasma IgA in pIgR KO mice a total IgA 
ELISA was performed. Plasma IgA in the pIgR KO mice was higher than in the 
wild type C57BL6 controls. Statistical analysis revealed that this difference was 
highly significant (Figure 3.3; p < 0.01). 
 Figure 3.3 Plasma IgA in pIgR KO mice and wild type C57BL6 
controls. 
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The pIgR KO mice had higher plasma IgA compared to the C57BL6 WT 
controls. ** indicates p < 0.001. Plasma dilution 1:100. 
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Impaired IgA secretion does not affect weight gain or fat 
accumulation in Western Diet fed mice. 
Previous studies have linked the intestinal bacteria to increased weight 
gain and body-fat accumulation [67, 171]. Considering the magnitude of IgA 
transport by the pIgR, it is plausible that impaired IgA secretion could lead to 
changes in the composition of the intestinal bacteria. This could result in changes 
in bodyweight and fat accumulation. The bodyweights of pIgR KO mice and wild 
type C57BL6 controls were measured prior to commencing the Western Diet 
feeding regimen.  
Both groups of mice showed similar patterns of weight gain throughout the 
duration of the feeding study. At no point in the study did the bodyweights differ 
significantly between the C57BL6 mice and the pIgR KO mice (Figures 3.4A and 
3.4B). EchoMRI™ analysis gave similar body fat percentage values for the 
C57BL6 controls and the pIgR KO mice (Figure 3.4C). These results suggest that 
the absence of the polymeric immunoglobulin receptor does not significantly alter 
the accumulation of body fat or weight gain.  
Absence of pIgR does not increase plasma inflammatory markers in 
Western Diet fed mice. 
Plasma from the C57BL6 wild type controls and the pIgR KO mice was 
analyzed by MILLIPLEX® Mouse Cytokine Kits to see if consumption of a high-
fat, high-carbohydrate Western Diet in conjunction with impaired IgA secretion 
would promote increased systemic inflammation.  The plasma from the C57BL6 
controls and the pIgR KO mice was analyzed prior to commencing the Western 
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Diet as well as two and sixteen weeks after commencing the Western Diet 
feeding regimen. No differences were observed between the C57BL6 controls 
and the pIgR KO mice in plasma IL-1b, IL-6, IL-10 and TNF-α at any time point 
(Figures 3.5 A, 3.5 B, 3.5 C and 3.5 D). No differences were observed in plasma 
IL-13, IL-12, IL-5 and IL-7 (Figures 3.6 A, 3.6 B, 3.6 C and 3.6 D). These results 
indicate that there are no baseline differences in plasma inflammatory cytokines 
between C57BL6 controls and pIgR KO mice prior or subsequent to consuming a 
high-fat, high-carbohydrate Western Diet.  
Plasma adipokine levels were also analyzed subsequent to commencing 
the Western Diet feeding regimen. Notably, the pIgR KO had reduced plasma 
PAI-1 compared to the C57BL6 controls. Statistical analysis revealed that this 
difference was significant (Figure 3.7 B).  There were no differences between the 
C57BL6 controls and the pIgR KO mice in plasma insulin or resistin (Figures 3.7 
A and 3.7 C). Plasma IL-6 and TNF-α were below the detectable range in the 
C57BL6 controls and the pIgR KO mice. These results provide evidence that the 
absence of the polymeric immunoglobulin receptor does not promote increased 
systemic inflammation either in the presence or absence of high-fat diet 
consumption. It should be noted that plasma adipokine levels were not measured 
in these mice prior to commencing the Western Die and as a result there is no 
baseline date for the plasma adipokine values.  
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Figure 3.4. Bodyweight and body fat analyses 
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 (A) C57BL6 controls and pIgR KO mice had similar bodyweights 
throughout the duration of the study (B) Percentage of bodyweight relative to the 
initial bodyweight was calculated. There was no difference in percentage weight 
gain. (C) There was no significant difference in percentage body fat between 
C57BL6 mice and pIgR KO mice. 
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Figure 3.5  Plasma cytokine levels. 
 
 
Analysis of plasma from the C57BL6 wild type controls (n = 7) and the 
pIgR KO mice (n = 6) by the MILLIPLEX® Mouse Cytokine Kit (Millipore Catalog 
# MPXMYCTO-70K) after consumption of Western Diet at different time points. 
There were no differences between pIgR KO mice and C57BL6 controls in (A) 
Plasma IL-1b (B) Plasma IL-6. (C) Plasma IL-10 (D) Plasma TNF-α. 
 
IL-1b
Time (weeks)
p
g
/m
L
0 2 16
0
10
20
30
40
50
C57BL6
pIgR KO mice
IL-6
p
g
/m
L
0 2 16
0
10
20
30
40
50
C57BL6
pIgR KO mice
IL-10
Time (weeks)
p
g
/m
L
0 2 16
0
10
20
30
C57BL6
pIgR KO
TNFa
Time (weeks)
p
g
/m
L
0 2 16
0
5
10
15
20
25
C57BL6
pIGR KO
A B
C D
84 
 
Figure 3.6 Plasma cytokine levels. 
 
Analysis of plasma from the C57BL6 wild type controls (n = 7) and the 
pIgR KO mice (n = 6) by the MILLIPLEX® Mouse Cytokine Kit (Millipore Catalog 
# MPXMYCTO-70K) after consumption of Western Diet at different time points.  
There were no differences between pIgR KO mice and C57BL6 controls in (A) 
Plasma IL-13. (B)  Plasma IL-12 (C) Plasma IL-5. (D) Plasma IL-7.  
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Figure 3.7 Plasma adipokines 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of plasma from the C57BL6 wild type controls (n = 7) and the 
pIgR KO mice (n = 6) by the MILLIPLEX® Mouse Cytokine Kit (Millipore Catalog 
# MADPK-71K) after consumption of Western Diet at different time points (A). 
There were no differences in plasma insulin (B) Plasma PAI-1 was higher in 
C57BL6 wild type controls than pIgR KO mice. (C) No difference in plasma 
resistin. * indicates p < 0.05 
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Absence of pIgR does not result in increased plasma IgG against 
intestinal bacteria. 
Plasma anti-E. coli LF82 IgG was measured to determine whether the 
absence of the polymeric immunoglobulin receptor leads to enhanced epithelial 
invasion by invasive intestinal bacteria. There were no differences between the 
C57BL6 wild type controls and the pIgR KO mice in plasma IgG against invasive 
intestinal bacteria (Figure 3.8). 
Figure 3.8 Anti-E coli LF82 IgG in plasma 
 
 
 
 
 
 
 
Measurement of anti-E. coli LF82 IgG in plasma from the C57BL6 wild 
type controls (n = 7) and the pIgR KO mice (n = 6). There was no difference in 
plasma anti-E. coli LF82 IgG between both groups. Plasma dilution 1:100. 
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Absence of pIgR does not alter the percentages of immune cell 
subsets after long term Western Diet consumption. 
In order to determine whether the absence of the polymeric 
immunoglobulin receptor leads to increased inflammation after consuming a 
high-fat Western Diet, inflammatory immune cells were measured by the 
HEMAVET® 950 FS Multispecies Hematology System. Hematological analysis of 
whole blood revealed that there were no differences between the C57BL6 wild 
type controls and the pIgR KO mice in neutrophil percentage, basophil 
percentage, monocyte percentage and eosinophil percentage (Figures 3.9 A, 3.9 
B, 3.9 C, and 3.9 D). 
Absence of pIgR does not promote increased intestinal inflammation 
after long term Western Diet consumption. 
Real time PCR (RT-PCR) was performed in order to investigate whether 
the absence of pIgR in conjunction with long term consumption of a high-fat 
Western Diet can promote intestinal inflammation. TNF-α and IL-6 expression 
was measured in the ileum and the colon. These regions of the GI tract were 
selected for analysis since they harbor the largest bacterial populations. After 
sixteen weeks of consuming the Western Diet, no differences were observed 
between the C57BL6 controls and the pIgR KO mice in IL-6 expression in the 
ileum, and colon (Figures 3.10 A and 3.10 B).  There were no significant 
differences in TNF-α expression in the ileum and colon (Figures 3.10 C and 3.10 
D). These findings suggest that impaired IgA secretion by pIgR does not lead to 
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pro-inflammatory changes in the GI tract after long term consumption of a high-
fat Western Diet.   
Figure 3.9 Hematological analysis 
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Comparison of blood cell subsets in C57BL6 wild type controls (n = 7) and 
the pIgR KO mice (n = 6) after sixteen weeks of Western Diet consumption. 
There were no differences between pIgR KO mice and C57BL6 controls in (A) 
Neutrophil percentage (B) Basophil percentage (C) Monocyte percentage (D) 
Eosinophil percentage. Percentages of white blood cells are given. 
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Figure 3.10 Intestinal inflammatory markers  
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Intestinal inflammatory markers in C57BL6 wild type controls (n = 7) and 
the pIgR KO mice (n = 6) after sixteen weeks of Western Diet consumption. 
There were no differences between pIgR KO mice and C57BL6 controls in (A) 
Ileum IL-6 (B) IL-6 in the colon (C) Ileum TNF-α expression (D) TNF-α in the 
colon. 
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Absence of pIgR impairs insulin sensitivity after long term Western 
Diet consumption. 
Oral glucose tolerance tests (OGTTs) were performed in order to 
determine whether the absence of pIgR altered the ability to respond to an oral 
glucose challenge. OGTTs were conducted prior to commencing the Western 
Diet feeding regimen as well as at various time points throughout the feeding 
study. Area under the curve (AUC) analysis revealed that the ability to respond to 
an oral glucose challenge was similar in the C57BL/6 wild type controls and the 
pIgR KO mice prior to commencing the Western Diet (Figure 3.11 A).  
OGTT tests were subsequently performed at two, ten and sixteen weeks 
after the C57BL6 controls and pIgR KO mice were placed on the Western Diet 
feeding regimen. Area under the curve (AUC) analysis did not reveal any 
significant difference between the C57BL/6 controls and the pIgR KO mice in 
responding to an oral glucose challenge after two weeks on the Western Diet and 
ten weeks on the Western Diet (Figures 3.11 B and 3.11 C).  
However at the sixteenth week of the study the pIgR KO mice had an 
impaired ability to respond to an oral glucose challenge compared to the C57BL6 
controls (Figure 3.11 D). These results suggest that the absence of pIgR together 
with the consumption of a high-fat, high carbohydrate diet may negatively affect 
the ability to respond to an oral glucose challenge.  
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Figure 3.11 Oral glucose tolerance tests (OGTTs)  
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C57BL6 wild type controls (n=7) and pIgR KO mice (n=6). Area under the 
curve (AUC) analysis was performed. No differences between the AUC for pIgR 
KO mice and C57BL6 controls (A) Before commencing the Western Diet. (B) 
After two weeks on the Western Diet (C) After ten weeks on the Western Diet (D) 
After sixteen weeks on the Western Diet the difference between AUC for the 
C57BL6 controls and pIgR KO mice was statistically significant. * indicates p 
<0.05. 
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Decreased plasma IgA in obese diabetics.  
Analysis of the human plasma samples by total IgA ELISA revealed 
significant differences between the three groups of human subjects. The lean 
healthy controls had the highest levels of plasma IgA. Obese non-diabetics had 
significantly reduced plasma IgA compared to the lean controls (p < 0.05). There 
were also differences between plasma IgA between both groups of obese 
individuals. The obese diabetic group had plasma IgA that was significantly 
reduced compared to the obese non-diabetic group as well as the lean, healthy 
controls (Figure 3.12, p < 0.05).  
Figure 3.12: Human plasma IgA. 
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Figure 3.12: Human plasma IgA was assessed by total IgA ELISA in three 
groups of subjects. Lean healthy controls (Lean) had significantly higher levels of 
plasma IgA than obese non-diabetics (OND). Obese diabetics (OD) had 
significantly lower plasma IgA than obese non-diabetics. Sample sizes for Lean 
(n=10), OND (n =16) and OD (n =16). 
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DISCUSSION 
Long term HFD consumption decreases fecal IgA. 
Immunoglobulin A (IgA) secreted into the lumen of the GI tract minimizes 
adherence of intestinal bacteria to the intestinal epithelium. Since long term HFD 
consumption is linked to elevated plasma IgG against invasive intestinal bacteria, 
it is possible that IgA secretion into the lumen of the GI tract could be impaired. 
To determine whether this was the case, fecal IgA levels were measured in 
C57BL6 mice fed a HFD and a LFD diet on a weekly basis. It was expected that 
prior to commencing the feeding study that the fecal IgA levels would be similar. 
With time, fecal IgA levels in the HFD mice would decrease relative to the LFD 
controls. This study is not the first to investigate dietary intervention on fecal IgA 
production. The consumption of probiotic containing foods may improve overall 
health [172]. These improved indicators of health have been correlated with 
increased fecal sIgA levels. 
Prior to switching the mice to the special diets, both groups of mice had 
similar fecal IgA levels. However, by the fourth week of the feeding study there 
was a significant difference between the LFD mice and HFD mice. After four 
weeks HFD mice had significantly lower fecal IgA levels compared to LFD 
controls (Figure 3.1). However, fecal IgA/g feces did not decrease in the HFD 
mice. Instead what was observed was an increase in LFD mice relative to the 
HFD mice. When the mice were purchased they were five weeks old. The 
feeding study was commenced when they were six weeks old. 
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Secretory IgA production increases with age [173]. It is possible that in this 
feeding study an age effect was observed. B-1 cells play a major role in IgA 
production in the gut [174]. Furthermore, B-1 cells are adversely affected by 
consumption of high levels of dietary fat [175]. Therefore it is possible the 
differences between fecal IgA in LFD and HFD mice are a consequence of 
dietary fat inhibiting development of a normal immune repertoire in the HFD 
mice.  
The effect of long term HFD consumption on plasma IgA 
Long term HFD consumption did not appear to have an effect on plasma 
IgA in mice. After the ten week feeding study, both groups of mice had similar 
levels of plasma IgA (Figure 3.2). Considering the relatively small sample size in 
the study (n=6 for each group), it is likely that further studies should be performed 
using larger sample sizes.  
Absence of pIgR does not exacerbate inflammation. 
A major component of our study was to investigate whether the absence 
of active IgA secretion into the lumen of the GI tract by the polymeric 
immunoglobulin receptor (pIgR) is a predisposing factor for development of 
metabolic syndrome. As it has been previously mentioned, pIgR actively secretes 
polymeric immunoglobulins into the lumen of the GI tract. The quantity of IgA 
secreted into the lumen of the GI tract by pIgR is immense (an estimated three 
grams per day) [168, 176]. What is even more intriguing is that the pIgR 
traversing the IECs are never recycled. pIgR not bound to IgA is also secreted 
into the lumen of the GI tract as secretory component (SC). This raises the 
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question as to whether such an elaborate transport mechanism requiring a 
considerable input of energy serves a crucial purpose. We observed that long 
term HFD consumption led to increased plasma IgG against an invasive 
intestinal bacterial strain.  
In addition to our experimental findings, we were intrigued by the study 
performed by Gewirtz et al. That study utilized mice deficient in the Toll-like 
receptor 5 (TLR5) [171]. TLR5 binds flagellin, a constituent of intestinal bacteria 
[177]. TLR5 KO mice developed features of the metabolic syndrome. These 
include increased weight gain, adiposity and insulin resistance. Since TLR5 KO 
mice are unable to respond to flagellin containing bacteria, it is probable that that 
these mice have an altered intestinal bacterial population from wild type control 
mice.  
Since pIgR KO mice lack a specialized method of transporting pIgA, it was 
reasonable to hypothesize that a significant reduction in the amount of stable 
secretory IgA could result in a drastically altered intestinal bacterial composition. 
It was expected that a combination of an intestinal bacterial population enriched 
in pathogenic strains and long term consumption of a high-fat, high-carbohydrate 
Western Diet would lead to metabolic dysregulation as well as increased 
systemic inflammation. 
A wide range of parameters were evaluated prior to commencing the 
Western Diet feeding regimen. These included body weight and body fat, plasma 
inflammatory cytokines and the ability to respond to an oral glucose challenge. 
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Considering the vast quantity of IgA secreted into the lumen of the GI tract, we 
reasoned that pIgR KO mice would be more susceptible to epithelial invasion by 
invasive intestinal bacteria. Instead it was observed that plasma IgG levels 
against invasive intestinal bacteria was similar in both pIgR KO mice and the 
C57BL6 littermate controls.  
No significant differences were observed in these parameters between the 
pIgR KO mice and the C57BL6 littermate wild type controls prior to commencing 
the Western Diet feeding regimen. The mice used were relatively young (age six 
weeks). It is likely that during the nursing stage both groups of mice received 
ample amounts of IgA from the breast milk thereby negating any potential 
differences in intestinal bacteria due to the deficiency in pIgR. Despite the 
obvious difference in IgA secreting capacity, the lack of differences in metabolic 
parameters prior to consuming the Western Diet feeding regimen was not 
unexpected. 
Body weight, body fat percentage, plasma inflammatory cytokines, 
immune cell subsets, intestinal inflammation and oral glucose tolerance were 
evaluated prior to commencing the Western Diet feeding regimen, as well as at 
various points subsequent to commencing the Western Diet. There were no 
differences in plasma inflammatory cytokines between pIgR KO mice and 
C57BL6 wild type controls either prior to commencing the Western Diet or at any 
point during the feeding study. With the exception of PAI-1, plasma adipokine 
levels did not differ at 8 or 16 weeks after commencing the Western Diet feeding 
regimen.  
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There were no baseline differences in the ability to respond to an oral 
glucose challenge between the pIgR KO mice and C57BL6 wild type controls. 
Two and ten weeks after commencing Western Diet feeding  there were no 
differences in responding to an oral glucose challenge between  pIgR KO mice 
and C57BL6 wild type controls. However after sixteen weeks on the Western Diet 
area under the curve (AUC) analysis revealed that pIgR KO mice had impaired 
responses to an oral glucose challenge compared to C57BL6 controls.  
After performing euthanasia on both groups of mice, intestinal 
inflammation was measured. There were no differences in any of these 
parameters between pIgR KO mice and C57BL6 controls.  This was surprising 
given the fact that a large quantity of IgA is secreted into the lumen of the GI tract 
by pIgR. However, there are a few possible explanations as to why no 
differences in intestinal inflammation were observed between the C57BL6 and 
the pIgR KO mice. First of all, this study lasted for a shorter duration than the 
study using TLR5 KO mice. Whereas this study was performed for a total of 16 
weeks, the study performed by Gewirtz et al was a twenty week feeding study.  It 
is possible that the effects of pIgR deficiency had not yet become apparent.  
Another possible reason no differences were observed between both 
groups of mice is because pIgR KO mice are not completely deficient in intestinal 
IgA. A study performed by Johansen et al, compared fecal IgA levels in pIgR KO 
mice and wild type controls [170]. Fecal IgA was measured in pIgR KO mice and 
C57BL/6 controls by ELISA. Statistical analysis revealed that fecal IgA in pIgR 
KO mice was less than in the C57BL/6 controls. However, IgA was still 
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detectable in the feces of pIgR KO mice despite their inability to actively secrete 
IgA. This is because plasma IgA diffuses into the intestinal mucosa by 
paracellular diffusion. Furthermore, pIgR KO mice have significantly elevated 
fecal IgG which may confer protection against the intestinal bacteria.  
We observed impaired responses to an oral glucose challenge at the end 
of the study in the pIgR KO mice compared to the wild type C57BL6 mice. 
However this did not correspond to an increase in plasma and intestinal 
inflammatory cytokines. It is possible that the MILLIPLEX analysis was not the 
best method of evaluating systemic inflammation. Furthermore, in the intestinal 
tissue only a limited number of inflammatory markers were examined. Perhaps, a 
wider range of inflammatory markers need to be examined. The study of long 
term HFD consumption on pIgR KO mice is inconclusive and should be repeated 
with pIgR KO mice housed separately from wild-type controls.    
Reduced plasma IgA in obese diabetics. 
Analysis of the human plasma samples revealed differences between the 
three groups of human subjects. The lean controls had the highest levels of 
plasma IgA. Obese non-diabetics had significantly reduced plasma IgA 
compared to the lean controls. Obese diabetics had significantly reduced plasma 
IgA compared to both obese non-diabetics and lean controls (Figure 3.12). 
Relatively little is known about the precise role of plasma IgA. This has been 
attributed to difficulties in purification of plasma IgA. Plasma IgA can neutralize 
antigens. However, it has a poor ability to promote opsonization. There are a 
number of effector functions possessed by plasma IgA. These include 
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enhancement of antibacterial effect of lactoperoxidase and suppression of 
inflammatory effects of immune lysis, NK cell activity and antibody dependent 
cellular toxicity.  
Reduced serum IgA is more prevalent in individuals who have lost 
tolerance to normal food antigens [178]. Serum IgA neutralizes normally 
‘harmless’ antigenic material such as food antigens and autoantigens. Serum IgA 
clears these antigens from the systemic circulation in a non-inflammatory 
manner. It is has been suggested that IgA clearance of antigens prevents 
inappropriate responses to these antigens [179]. The higher prevalence of 
autoimmune disorders in IgA deficient individuals has been attributed 
inappropriate immune destruction of these antigens [180-182]. Thus the 
significant decrease in plasma IgA in obese-diabetics may have led to 
inflammatory immune responses that in turn led to insulin resistance.  
However, further analysis is needed on plasma IgA levels with regards to 
type 2 diabetes. A previous study by Gill et al noted that type 2 diabetics had 
higher plasma IgA levels than healthy controls  [183]. This was attributed to the 
fact that some of the diabetic individuals in that study had acute or chronic 
bacterial infections. Furthermore, subclinical infections could not be ruled out in 
the diabetics who did not have bacterial infections. A possible reason for the 
reduced plasma IgA in obese diabetics is a defect in IgA synthesis.  
 
Copyright © Nadeem K. Mohammed 2012 
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CHAPTER 4 DISCUSSION  
EVALUATION OF PROPOSED HYPOTHESIS. 
Our preliminary findings led us to propose that long term consumption of a 
high fat diet could impair intestinal IgA production, facilitating adherence and 
invasion of the intestinal epithelium by the commensal bacteria. Invasion of the 
intestinal epithelium by the commensal bacteria could trigger inflammatory 
responses, which in turn could impair insulin signaling, culminating in the 
development of type 2 diabetes.  
Decreased IgA production by long term HFD consumption: Over the 
course of a long term (10 week) feeding study C57BL6 mice fed a low fat diet 
(10% kCal from fat) experienced an increase in fecal IgA production relative to 
mice fed a high fat diet (60% kCal from fat). These findings provided evidence 
that consumption of high levels of dietary fat may impair the mucosal IgA barrier.  
Revision to proposed model-Invasion of the intestinal epithelium by 
invasive bacteria: Initially we proposed that long term consumption of a high fat 
diet could result in the commensal bacteria being able to breach the intestinal 
epithelium and elicit inflammatory responses. However, a major limitation of our 
preliminary studies was the exclusive use of E. coli LF82, an invasive intestinal 
bacterial strain. To address this concern non-invasive intestinal bacteria were 
analyzed. IgG against E. coli Nissle 1917, Bacteroides thetaiotaomicron and 
Lactobacilus acidophilus was measured in the plasma of HFD and LFD mice. 
Plasma IgG against these bacterial strains was measured using the lab based 
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ELISA. There were no significant differences in IgG against these bacteria in LFD 
mice or HFD mice (Figures 2.4 B, 2.4 C and 2.4 D).  
The studies cited earlier using GF mice suggested that the presence of 
intestinal bacteria is required for the negative effects of long term HFD 
consumption. However, none of those studies examined the role of specific 
intestinal bacterial species. The findings of our studies provide evidence that 
invasive intestinal bacterial strains are associated with inflammation and insulin 
resistance.  
The other intestinal bacterial strains examined are beneficial to the host. 
E. coli Nissle 1917 (EcN) is a widely studied probiotic. Probiotics are viable 
microbes which may confer health benefits when consumed [184]. The ability of 
EcN to confer health benefits has been known for almost a century since the First 
World War when it was isolated from a lone soldier who did not succumb to 
enterocolitis. Investigations on the effects of EcN supplementation show 
promising results for treating colitis [185, 186]. An interesting coincidence is that 
EcN has been utilized to counteract the effects of the LF82 strain of E. coli [187]. 
Reports have also provided evidence that Bacteroides thetaiotaomicron may 
prevent rotavirus infections [188]. It has been reported that Lactobacilus 
acidophilus has the ability to diminish inflammation caused by Helicobacter pylori 
[189]. By contrast, the LF-82 strain of E. coli has been described as being 
invasive in nature [151].  E. coli LF82 was isolated from an ileal lesion of a 
Crohn’s Disease patient [150]. E. coli LF82 is designated as an adherent invasive 
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E. coli strain (AIEC strain). Invasive strains are characterized by their ability to 
enter epithelial cells and subsequently survive and replicate.  
Immune responses against invasive intestinal bacteria are associated with 
inflammation. In these studies a statistical correlation between anti-E. coli LF82 
IgG and TNF-α was observed.  The correlation analysis was performed using the 
plasma samples from the obese patients. Both groups had equivalent mean BMI 
values, ruling out differences in adiposity as a TNF-α source. The correlation 
between anti-E. coli LF82 IgG and TNF-α provided evidence that immune 
responses to the intestinal bacterial antigens are associated with inflammation. It 
is possible that the increase in IgG against intestinal antigens promoted cross-
linking of FcγRs, which in turn caused the release of TNF-α. 
Inflammatory responses resulting from invasion of the intestinal epithelium 
impairs insulin signaling. Elevated plasma anti-E. coli LF82 IgG in the HFD mice 
provided evidence that long term consumption of high levels of dietary fat is 
associated with invasion of the intestinal epithelium by invasive bacteria. 
Increased plasma TNF-α and neutrophil percentage in the blood of HFD mice 
suggests that a consequence of epithelial penetration by invasive bacteria is 
inflammation. Inflammation is associated with a variety of disease states.  
One of these conditions is type 2 diabetes. The increase in fasting blood 
glucose levels in HFD mice compared to LFD mice was significant (Figure 5B, 
p<0.05). It is possible that elevated anti-E. coli LF82 IgG against intestinal 
bacteria led to increased  cross-linking of FcγRs with the Fc domains. This in turn 
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may have led to increased TNF-α secretion as well as increased neutrophils in 
the blood. The chronic inflammation could have in turn impaired insulin signaling 
pathways, leading to the development of insulin resistance. 
Significance of studies.  
These studies have significant clinical relevance. Although there is 
widespread awareness about the risk factors for developing type 2 diabetes, the 
prevalence of obesity and metabolic syndrome has continued to rise. This has 
been costly as treatment and the loss of productivity due to various disabling 
complications of type 2 diabetes continue to burden the healthcare sector. The 
research into novel mechanisms of treating type 2 diabetes is in itself a tacit 
admission that it is impossible to expect the tens of millions of overweight 
individuals to alter their lifestyle radically enough to maintain a healthy 
bodyweight.  
Apart from individuals with Crohn’s Disease the LF82 strain of E. coli is 
rare. It is unlikely that a large percentage of individuals harbor this particular 
strain. However, E. coli LF82 may possess antigens that are shared by other 
intestinal bacterial species. The intestinal bacteria remain poorly characterized. 
There is a possibility that invasive intestinal bacterial strains that have not yet 
been identified reside in the GI tract. Long term HFD consumption may enhance 
the capacity of invasive bacterial strains to cross the IEC barrier. This can elicit 
inflammation leading to insulin resistance.  
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Furthermore, our findings may explain why some obese individuals 
develop type 2 diabetes whereas others do not. Individuals harboring invasive 
intestinal bacterial strains may be more prone to chronic inflammation and 
impaired insulin signaling. To more comprehensively define the role of the 
intestinal bacteria in promoting systemic inflammation, further studies will need to 
be performed. IgG against protein extracts from invasive intestinal bacterial 
strains can be measured in diabetics and non-diabetics. Based on our findings 
we expect that diabetics would have higher IgG against invasive intestinal 
bacterial strains. Comparison of IgG in a larger group of obese non-diabetics and 
obese-diabetics would give a better indication of whether long term HFD 
consumption enhances invasion of the IEC barrier by invasive intestinal bacterial 
strains. The clinical implications of these studies could be novel methods of 
treating type 2 diabetes. It is possible that specific anti-microbial compounds 
could be developed to selectively eliminate invasive intestinal bacterial strains 
residing in obese individuals. This could spare these individuals from developing 
type 2 diabetes. It would also reduce the financial burden to the healthcare sector 
significantly.  
Technical contributions.  
These studies resulted in technical contributions for assessing immune 
responses against the intestinal bacteria. ELISA kits to assay systemic immune 
responses against intestinal bacterial antigens were difficult to obtain. To address 
the lack of commercial ELISAs we developed our own lab based ELISA. This lab 
based ELISA is a reliable, reproducible assay for assaying the humoral immune 
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response against antigens from intestinal bacterial strains. To the best of our 
knowledge, no one had developed the methods of Western Blotting to analyze 
the levels of plasma IgG against intestinal bacterial proteins. Researchers hoping 
to assess the systemic immune response against intestinal bacterial strains in a 
timely manner can use the information provided in this publication. 
EVALUATION OF THESE STUDIES. 
Strengths: These studies were the first to investigate the association 
between specific intestinal bacteria and type 2 diabetes. Previous studies had 
linked the presence of intestinal bacteria to obesity, inflammation and insulin 
resistance. However, a key flaw of those studies was that they did not examine 
which particular bacteria resulted in the development of inflammation and insulin 
resistance. The findings of previous studies implicated that bacteria residing in 
the GI tract promoted the development of inflammation. Although there is 
extensive evidence supporting this proposal, it should be kept in mind that there 
are hundreds of bacterial species residing in the GI tract. Given the enormous 
diversity of the intestinal bacteria, it cannot be assumed that all intestinal bacteria 
are equally capable of promoting systemic inflammation and insulin resistance. 
As the results from our studies indicate, not all intestinal bacteria possess the 
same ability to cross the intestinal epithelial cell barrier.  
These studies provided a more definitive link between the intestinal 
bacteria, inflammation and insulin resistance. A critical component lacking in the 
previous studies in GF mice was showing that the inflammation observed as a 
consequence of HFD consumption was the result of intestinal bacteria. Although 
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the studies comparing GF mice to conventionally raised mice measured a variety 
of parameters, none of these studies performed immunological assays that 
showed immune responses to the intestinal bacteria. This study quantified 
plasma IgG against intestinal bacteria in addition to quantifying plasma TNF-α 
and fasting blood glucose values, linking all three parameters. 
Our studies characterized the effect of HFD consumption on the localized 
immune responses at the mucosal surface of the GI tract. Although previous 
studies had linked the intestinal bacteria to systemic inflammation and insulin 
resistance, none of these studies investigated whether this was due to 
impairment of the localized adaptive intestinal mucosal responses. It should be 
noted that the effect of impairment of the intestinal immunity on shaping the 
composition of the gut microbiota was examined by Gewirtz et al using TLR5 
deficient mice. However, their study looked at the deficiency of innate immune 
mechanisms in the GI tract. Our studies examined the effect of HFD consumption 
on the adaptive immune response to the intestinal bacteria. This is an important 
topic to address given the immense load of IgA secreted into the GI tract as well 
as the documented protective effects of IgA. 
Weaknesses: A major critique of this study is the extensive use of the 
LF82 strain of E. coli. as it has been previously stated, this strain of bacteria is 
recognized as an adherent invasive bacterial strain. Therefore it is not an ideal 
strain to use as an experimental model. This experimental model deficiency was 
addressed by assessing the effect of HFD consumption on the systemic immune 
response to the non-pathogenic bacteria E. coli Nissle 1917, Bacteroides 
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thetaiotaomicron and Lactobacilus acidophilus. Despite the fact that HFD 
consumption did not appear to alter the systemic immune response to these 
bacteria, Western Blot analysis showed that HFD mice had higher plasma IgG 
against the antigens present in the cecum of control mice. Higher plasma IgG 
against the antigens from the cecum in HFD mice strengthened our hypothesis 
that HFD consumption may lead to translocation of intestinal bacteria into the 
systemic circulation. However, at this point, the only bacterial strain to which the 
systemic immune response has shown to be increased as a result of HFD 
consumption the LF82 strain of E. coli.  
The findings of these studies point to the possibility that individuals 
harboring invasive intestinal bacterial strains are at increased risk of developing 
systemic inflammatory immune responses that may increase their risk of 
developing type 2 diabetes. However, these studies did not determine whether 
the composition of the gut microbes changed during the HFD feeding regimen. 
As a consequence, it is not known if HFD consumption increases the proportion 
of invasive intestinal bacteria. 
There were flaws in the assessment of HFD consumption on the localized 
immune responses at the mucosal surface of the GI tract. Although fecal IgA was 
quantified, no other immunoglobulin classes were measured. It is known that IgM 
plays a role in preventing the intestinal bacteria from adhering to the intestinal 
epithelium. Fecal IgM was not measured. Thus it is not conclusive as to whether 
HFD consumption impairs mucosal immunity. Furthermore, a number of 
mechanisms prevent the commensal bacteria in the lumen of the GI tract from 
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adhering to the intestinal epithelial cells. These include mucus production by 
goblet cells as well as the production of defensins, cathelicidins, phospholipases, 
lysozyme, and Reg III-gamma. These parameters were not examined in LFD 
mice and HFD mice.  
EXPERIMENTAL DESIGN.  
Lab developed ELISA: A key difference between the lab developed 
ELISA and the Western Blot analysis was that the Western Blot showed 
differences between the three groups of human subjects. Western Blot analysis 
indicated that plasma anti-E. coli LF82 IgG was highest in obese diabetics, 
followed by obese non-diabetics with the lowest plasma anti-E. coli LF82 IgG 
found in the lean healthy controls. On the other hand, ELISA analysis showed 
that the obese diabetics had significantly higher plasma anti-E. coli LF82 IgG 
than lean controls with no significant differences between the obese non-
diabetics and lean healthy controls. A possible explanation for this discrepancy is 
that the ELISA was prepared by extracting bacterial proteins using Bacterial 
Protein Extraction Reagent (B-PER). This reagent specifically extracts soluble 
proteins. It is possible that during the process of soluble protein extraction, non-
soluble proteins that possessed epitopes for immune recognition were lost. 
Furthermore, the lab-developed ELISA only consisted of soluble bacterial 
proteins. Non-protein compounds such as lipopolysaccharide (LPS) can also 
elicit immune reactions. LPS is a constituent of the outer cell membrane of gram 
negative bacteria including E. coli LF82. It is one of the more potent inducers of 
inflammation and results in the release of the pro-inflammatory cytokines TNF-α, 
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IL-6, and IL-1 [190-192]. However, despite these limitations we chose to perform 
the ELISAs since it was the most readily available method to give us quantitative 
measurements. There was concern that the lab developed ELISA optimization 
was not performed accurately. These do not negate our results since the 
Western Blots show distinct differences between LFD mice and HFD mice.  
Technical flaws of pIgR KO mouse study: The magnitude of active IgA 
secretion into the lumen of the GI tract suggests that there is a rationale behind 
this specialized mechanism of active IgA transport. Furthermore, pIgR KO mice 
have significantly increased serum IgG against intestinal bacterial antigens than 
C57BL6 wild type controls. There were a number of design flaws in these 
studies. The mice were not housed according to genotype. As a consequence, it 
was possible that differences in the gut microbe composition of both groups of 
mice were minimized by coprophagy. Consumption of the fecal pellets produced 
by the wild type C57BL6 mice could result in harmless commensal bacteria being 
repopulated in the GI tract of the pIgR KO mice. These bacteria could in turn out-
compete any invasive strains, thereby preventing the anticipated outgrowth of 
invasive bacterial strains in the pIgR KO mice.  Co-housing of pIgR KO mice with 
wild type C57BL6 controls also resulted in an additional source of IgA for the 
pIgR KO mice. Small quantities of IgA reach the lumen of the GI tract in pIgR KO 
mice via paracellular diffusion. The co-housed pIgR KO mice were provided with 
an additional source of IgA in the form of fecal pellets. In addition to the IgA 
reaching the lumen of the GI tract via paracellular diffusion, the pIgR KO mice 
also obtained IgA by coprophagy. This in turn could have compensated for the 
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lack of active IgA transport by the pIgR. These technical shortcomings should be 
addressed in future studies of the effect of HFD consumption on pIgR KO mice.  
Alternative reasons for increased plasma anti-E. coli LF82 IgG.  
A question that was not addressed in these studies is whether live 
invasive bacteria invade the epithelium. The assays performed in these studies 
involved quantification of plasma IgG against E. coli LF82, E. coli Nissle 1917, 
Bacteroides thetaiotaomicron and Lactobacilus acidophilus. However, there were 
no direct methods used to determine whether live bacteria had been able to 
invade the intestinal epithelium. Given the huge bacterial population in the GI 
tract it is inevitable that some leakage across the epithelium takes place. The 
mesenteric lymph nodes act as a barrier between the GI tract and the systemic 
circulation. Dendritic cells actively sample bacteria from the lumen of the GI tract. 
The MLNs prevent the dendritic cells carrying commensal bacteria from gaining 
access to the systemic circulation. HFD consumption results in atrophy of the 
mesenteric lymph nodes and a reduction in the numbers of regulatory T 
lymphocytes.  It is possible therefore that increased systemic immune responses 
resulted from defects in the immune repertoire, not increased IEC invasion by the 
intestinal bacteria.  
 FUTURE DIRECTION OF STUDIES.  
Resolving technical issues of these studies: These studies linked the 
presence of systemic immune responses against intestinal bacteria to the 
development of type 2 diabetes. However there are a number of technical issues 
that need to be resolved. The lab based ELISA assay needs to be optimized by 
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preparing serial dilutions and plotting standard curves in order to determine the 
dynamic or linear portion of the standard curves. This would make quantification 
of plasma IgG more accurate.  
Another technical issue was the oral glucose tolerance tests performed in 
the Western Diet feeding study using the pIgR KO mice. The OGTTs were 
performed by administering an oral gavage of 2.0g/kg glucose. The blood 
glucose levels were beyond the detectable limit of the TrueTrack glucose meter 
at various time points subsequent to the oral gavage. To address this issue, an 
oral gavage of either 1.5g/kg glucose 1.0g/kg glucose needs to be administered 
to the mice.  
The effect of HFD consumption on the systemic immune response: 
Although there is now considerable evidence that the bacteria residing within the 
GI tract may promote systemic inflammation and insulin resistance, there are still 
some issues that need to be addressed. The first is to provide evidence that 
intestinal bacteria other than the LF82 strain of E. coli are associated with 
systemic inflammation and insulin resistance. This method may rely on preparing 
extracts from the cecums of control mice and performing Western Blots to assess 
IgG levels in the plasma of HFD mice and LFD mice. If HFD consumption is 
associated with increased plasma IgG against antigens from the cecum, then 
proteomic analysis could be performed to decipher what antigens are eliciting the 
systemic immune responses. This would be advantageous because identification 
of antigens triggering a systemic immune response would aid in identifying 
specific bacteria capable of penetrating the mucosal layer. Furthermore, these 
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antigens can be used for developing ELISAs for further quantitative assays of 
HFD consumption and systemic IgG responses against bacteria resident in the 
gut.  
It is also necessary to determine when the intestinal bacteria associated 
with systemic inflammatory immune responses are present. On one hand it is 
possible that some individuals harbor invasive intestinal strains that make them 
more prone to developing systemic inflammatory immune responses. On the 
other hand, HFD consumption may alter the composition of the intestinal bacteria 
resulting in an outgrowth of intestinal bacteria that may promote inflammation. To 
assess the relationship between HFD consumption and the intestinal bacteria a 
time course analysis could be performed. Fecal pellets can be collected from 
mice prior to commencing a HFD feeding regimen. The bacteria present in the 
feces can be characterized by 16SrRNA sequencing. Fecal pellets can be 
collected at various time points during feeding study and the bacteria present can 
be sequenced. These can then be referenced to LFD controls. This would 
indicate whether HFD consumption alters the intestinal bacteria over time.  
Our studies did not detect the presence of intestinal bacteria in the 
systemic circulation. Instead, we measured systemic immune responses against 
intestinal bacterial antigens by Western Blots and ELISAs that measured serum 
immunoglobulin G (IgG) responses to bacterial antigens. Trying to detect the 
presence of intestinal bacteria would have provided evidence that adherent 
bacteria breach the intestinal epithelium.  
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HFD consumption and mucosal immunity: To further characterize the 
effect of HFD consumption on the immune responses at the mucosal surface of 
the GI tract, fecal IgM will have to be measured in LFD mice and HFD mice. This 
would further strengthen the argument that mucosal immunity is impaired by HFD 
consumption. Additionally, intestinal sections can be immunostained for IgA, IgM 
and IgG in HFD mice and LFD mice. Comparisons of these IgG classes at the 
epithelium and the lamina propria may give a more comprehensive indication as 
to how HFD consumption affects immunity at the mucosal surface. 
One proposed experiment was to characterize the role of IgA responses in 
the GI tract using IgA knockout mice. The proposed study involved measuring 
and comparing body weight, adiposity, plasma inflammatory cytokines, intestinal 
inflammation and insulin resistance in mice lacking the gene for IgA production 
(IgA KO mice) and C57BL6 wild type controls. These parameters were supposed 
to be measured prior to commencing a high-fat, high-carbohydrate Western Diet 
and at different time points during the feeding study.  
IgA knockout mice are unable to synthesize IgA. This is because these 
mice lack the gene for the switch and constant regions [179]. IgA is undetectable 
in the serum and gastrointestinal secretions of IgA KO mice. Since mucosal IgA 
is important in restricting bacteria to the lumen of the GI tract, it is possible that 
the mucosal barrier of IgA KO mice may be impaired in comparison to wild type 
controls. It should be noted that IgA KO mice have significantly increased IgM 
and IgG levels in intestinal secretions. Elevations of IgM and IgG in the intestinal 
secretions of IgA KO mice may be compensatory mechanisms for the lack of IgA.  
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Therefore future evaluation of the effect of HFD consumption should not 
focus on one specific aspect of mucosal immunity. A more comprehensive array 
of parameters should be evaluated. Since the commensal bacteria residing in the 
GI tract do not cause problems in most individuals, millions of years of co-
evolution could have resulted in a number of redundant mechanisms to restrict 
bacteria to the GI tract lumen. As a result future studies should not only focus 
exclusively on IgA, but IgM as well as the production of mucus and anti-microbial 
peptides. 
Concluding statement: 
The results of these studies show that long term HFD consumption in mice 
is associated with increased plasma IgG against invasive intestinal bacterial 
strains. This is a revision from our proposed experimental model.  HFD mice had 
higher levels of IgG against invasive intestinal bacteria than LFD mice. However, 
there were no significant differences in plasma IgG against the non-invasive 
intestinal bacterial strains E. coli Nissle 1917, Bacteroides thetaiotaomicron and 
Lactobacilus acidophilus in HFD and LFD mice. These findings are clinically 
relevant since obese-diabetics had significantly higher plasma IgG against the 
invasive intestinal bacteria than lean healthy controls. Furthermore, a correlation 
exists between TNF-α and IgG against E. coli LF82. Increased anti-E. coli LF 82 
IgG and plasma TNF-α in obese-diabetics established a link between systemic 
immune responses against invasive intestinal bacterial strains, systemic 
inflammation and insulin resistance. The effect of long term HFD consumption on 
the secretory immune response in the intestinal mucosa was also investigated. It 
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was observed that fecal IgA levels were lower in HFD mice compared to LFD 
mice. These findings provide evidence that long term HFD consumption may 
reduce sIgA present in the lumen of the GI tract. Reduced sIgA may promote the 
translocation of pathogenic intestinal bacterial strains into the systemic 
circulation.  
 
Figure 4.1: A proposed model based on our experimental findings of 
how the intestinal bacteria can promote inflammation and insulin 
resistance.  
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